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Alcohol use disorder (AUD) is prevalent and associated with significant mortality and 
socioeconomic costs globally. Despite the tremendous burden of AUD, mechanisms of alcohol 
(ethanol) action that underlie the development of AUD are still not known. This dissertation 
addresses the role of epigenetic modifications in heritability of AUD and mechanisms of ethanol 
by testing three distinct hypotheses: 1) paternal ethanol exposure regulates ethanol drinking and 
ethanol-related behavior in offspring; 2) acute ethanol induces conserved changes to histone 
modifications at model gene promoters in the cerebral cortex; 3) chronic intermittent vapor 
ethanol and withdrawal induce dynamic changes in gene regulation via discrete histone 
modifications in accumbal dopamine 1 receptor positive medium spiny neurons. To test these 
hypotheses, this dissertation developed new models for studying heritability of ethanol drinking 
using paternal vapor ethanol exposure and epigenetic modifications in a neuronal subtype using 
fluorescence activated cell sorting. The results presented in this thesis provide evidence for 
epigenetic effects of ethanol in mediating heritability of ethanol drinking and sensitivity to 
ethanol selectively in male offspring as well as ethanol-induced gene regulation in the cerebral 
cortex. Additionally, they set up future studies of ethanol’s epigenetic mechanisms in neuronal 
subtypes, which will increase sensitivity of current assays to detect cell-specific changes in gene 
regulation. These results are expected to have important implications for the development of 
drugs that target epigenetic modifying enzymes for treatment of AUD. 
EPIGENETIC EFFECTS OF ETHANOL 
Andrey Finegersh, Ph.D. 
University of Pittsburgh, 2014
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1.0  INTRODUCTION 
1.1 ALCOHOL USE DISORDER AND ITS HERITABILITY 
The Diagnostic and Statistical Manual of Mental Disorders, 5th edition, (DSM-V) classifies 
pathological alcohol consumption under a single entity known as alcohol use disorder (AUD) 
[1]. AUD is diagnosed by a range of criteria related to tolerance to the subjective effects of 
alcohol, severity of withdrawal symptoms, and impairment of psychosocial functioning. AUD is 
a chronically relapsing disorder and its etiology is complex, overlapping with other substance use 
disorders. Initially, alcohol use is impulsive and characterized by positive reinforcement that 
converts to compulsive use with increasing negative reinforcement, the development of 
tolerance, and escalation of alcohol drinking. Ultimately, there is loss of control of alcohol 
drinking and the development of a negative emotional state, which makes it challenging to 
overcome alcohol use (for review, see [2]). 
 AUD is a major public health concern and associated with substantial costs to both 
individuals and society. In the United States, alcohol consumption contributes to $223 billion in 
societal costs annually [3]. Excluding accidents and homicides by people under the influence of 
alcohol, alcohol contributes to 1% of deaths annually in the United States [4]. This places 
alcohol use as the third leading modifiable factor contributing to death after tobacco use and poor 
diet and physical activity [5]. Despite its tremendous burden and ubiquitous use, there are few 
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available pharmacological treatments for AUD and relapse rates are ~50% three years after onset 
of treatment [6,7]. These issues demonstrate the urgency for developing novel agents for 
treatment of AUD and uncovering potential biomarkers associated with its risk. 
 The lifetime prevalence of AUD is 30% in the United States [8], highlighting the 
significant genetic and environmental differences that are likely among such a large cohort. This 
diversity is further complicated by the wide spectrum of alcohol consumption among humans, so 
that rate and quantity of alcohol consumed are not considered in DSM-V criteria for AUD [1]. 
Heterogeneity has made drug development for AUD challenging, since factors promoting 
pathological alcohol consumption are likely to be complex and varied between subjects. Despite 
this diversity, twin and adoption studies consistently find that AUD has a heritability of ~50% 
[9-11], indicating transmission of risk alleles from parents to offspring independent of 
environment. Heritability of AUD is comparable to other common, complex human diseases 
with significant gene-environment interactions like diabetes and major depressive disorder 
[12,13]; though, notably, it is lower than the ~75% heritability reported for nicotine dependence 
[14]. The discovery of AUD heritability has allowed researchers to search for specific gene 
polymorphisms associated with alcohol consumption. 
Early candidate gene studies for AUD risk identified alcohol metabolism genes as 
modifiers of alcohol consumption. Nineteen aldehyde dehydrogenase (ALDH) and seven alcohol 
dehydrogenase (ADH) genes are present in the human genome and involved in metabolizing 
endogenous and ingested alcohols. Polymorphisms inactivating the ALDH2 gene have been 
found almost exclusively in Asian populations and are associated with decreased risk for 
developing AUD [15-17]. ADH1 and ADH7 single nucleotide polymorphisms (SNP) have been 
associated with alcohol metabolism and consumption in European and African populations 
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[18,19]. These associations underlie the mechanism of action of disulfiram, one of the three FDA 
approved drugs for treatment of AUD. Disulfiram inhibits ALDH and leads to an accumulation 
of acetaldehyde, an ethanol metabolism intermediate associated with “hangover” symptoms. By 
associating alcohol consumption with an aversive reaction, disulfiram decreases alcohol 
consumption and reduces rates of relapse [20]. This example illustrates the potential of 
identifying variants protective for AUD for the development of pharmaceuticals to treat AUD. 
Studies of larger populations have been less successful at identifying risk alleles for 
AUD. One recent genome-wide association study (GWAS) did not identify any SNPs 
significantly associated with alcoholism risk and estimated that all of the SNPs studied 
accounted for only 0.1% of the genetic risk for developing alcoholism [21]. Other groups have 
found SNPs significantly associated with AUD using GWAS but later failed to replicate their 
results [22,23]. More recent meta-analyses and expanded studies have identified novel SNPs 
significantly associated with AUD [24,25], though differences in the SNPs discovered between 
studies suggest they may not be meaningful across the entire population. “Missing heritability” is 
a recent concept that refers to the failure of GWAS to uncover risk alleles for diseases with high 
heritability. While technical issues and the contribution of rare genetic variants may be masking 
these alleles [26], it is also possible that heritable variants outside the DNA sequence, known as 
“epi-alleles,” may be contributing complex phenotypes like AUD.  
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1.2 EPIGENETICS 
1.2.1 Epigenetic regulation of gene expression 
Epigenetics refers to a broad group of modifications to DNA and RNA structure without a 
change in nucleotide sequence. These mechanisms are the primary drivers for regulating gene 
expression, so that a single genome can give rise to the hundreds of cell lineages within an 
organism. The ability of epigenetic mediators to interact at several points along the genome 
makes them vital to normal cell function and aberrant epigenetic programming has been 
implicated in the development of cancer [27], addiction [28], and other human diseases. 
Epigenetic modifications are also mitotically and meitoically heritable [29], contributing to their 
role in development and heritability of phenotypes. With the sequencing of the human genome, 
there is now a shift toward mapping of the “epi-genome” to better understand the role of 
epigenetic modifications in disease [30]. 
In eukaryotes, DNA is condensed around a core of eight histone proteins into a nucleic 
acid-protein complex known as chromatin (Fig. 1). The functional unit of chromatin is the 
nucleosome, which consists of a single histone octamer and the ~147 bp of DNA that wrap 
around it. Histone octamers consist of homo- and heterodimers of four subunits, H2A, H2B, H3, 
and H4, with all but H4 encoded by multiple genes to generate histone subunit variants [31]. All 
histone proteins are rich in basic amino acids that carry a net positive charge within the cell, 
imparting a strong affinity for the negatively charged DNA phosphodiester backbone.  
The affinity between histones and DNA is critical for regulation of gene expression and is 
altered by covalent modifications to histone N-terminal tails [32]. For example, acetylation of 
lysine residues neutralizes the positive charge on lysine’s ammonium group, reducing its affinity 
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for DNA; weaker histone-DNA interactions increase accessibility of DNA to transcription 
factors, which recruit RNA polymerase to initiate transcription [33]. Methylation of lysine’s 
ammonium group can promote or repress gene expression depending on its location on the 
histone subunit N-terminal tail [34]. It is important to note that histone modifications are rapidly 
reversible and catalyzed by a diverse group of histone modifying enzymes, so that they are a key 
mechanism of cellular adaptation to the environment [32]. However, their role in gene regulation 
is complex, as recent studies have identified over 100 post-translational modifications to histones 
and the function of most of these is unknown [35]. Combinatorial approaches are only recently 
emerging to study how modifications interact with one another to alter gene expression [36].  
 
Figure 1. Epigenetic regulation of gene expression 
DNA (blue strand) wraps around a histone octamer to form the nucleosome. Chromatin 
condensation is promoted by histone and DNA methylation (Me) via DNA methyltransferases 
(DNMT), lysine methyltransferases (e.g., EZH2), and histone deacetylases (HDAC). These 
modifications are reversible and an open chromatin conformation is induced by histone acetylation 
(Ac) via histone acetyltransferases (HAT), which weaken histone-DNA interactions to promote 
transcription factor binding, recruitment of RNA polymerase, and transcription. 
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 The primary covalent modification to DNA in vertebrates is the methylation of cytosine 
preceding guanine (CpG dinucleotide). CpG dinucleotides occur much less frequently 
throughout the genome than would be expected by chance, most likely due to deamination of 
methylcytosine to thymine [37]. However, near transcriptional start sites of most mammalian 
genes, the density of unmethylated CpG dinucleotides is increased at regions known as “CpG 
islands” [38,39]. CpG islands show tissue specific patterns of methylation and only ~8% are 
hypermethylated in most cell types, with methylation associated with gene silencing [40]. DNA 
methylation is also a key mechanism for repression of retroviral elements in the genome [41]. 
The role of DNA methylation outside of CpG islands, at intra- and intergenic regions that 
account for 98% of CpG dinucleotides in the genome, is less clear. One recent study proposed 
that many of these form lower-density CpG islands with tissue-specific patterns of methylation 
[40]. Recent evidence is also emerging that intragenic methylcytosine may promote gene 
expression (for review, see [42]). Therefore, while DNA methylation is primarily associated with 
gene silencing, it may also play a role in transcription. 
DNA methylation at CpG islands represents a more stable mechanism of transcriptional 
repression than histone modification. Several studies have shown that nucleosome repression, 
through histone methylation and induction of the polycomb repressive complex, precedes DNA 
methylation and that DNA methylation may “lock” gene promoters into a repressive state [42-
44]. Timing of DNA methylation during development also supports this idea. The de novo DNA 
methyltransferases, DNMT3a and DNMT3b, are highly expressed following genome-wide 
demethylation of the early embryo [45]. These enzymes are also present in adult somatic tissue; 
however, the rate of de novo DNA methylation is much slower after embryogenesis, on the order 
of weeks to months [46,47]. Slow induction of de novo DNA methylation may represent a 
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cellular mechanism to maintain transcriptional plasticity. This idea is further supported by the 
lack of a well-defined mechanism for active demethylation in adult somatic tissue [48]. Ten-
eleven translocase (TET) enzymes have recently been proposed to mediate active demethylation 
by oxidation of 5-methylcytosine to 5-hydroxymethylcytosine (5-hmC) [49], and this process is 
necessary for early embryo development [50]. However, while 5-hmC is present in the brain and 
other tissues [51], its function is still unclear. While DNA methylation appears to be mostly fixed 
in adult tissue, more research is necessary to identify how DNA methylation and demethylation 
are induced in terminally differentiated cells and whether they represent normal homeostatic 
mechanisms for altering gene expression or are vestiges of early developmental programming. 
1.2.2 The role of epigenetic modifications in drug addiction 
This section summarizes general epigenetic mechanisms of drugs of abuse; a more detailed 
discussion of ethanol-induced epigenetic modifications is included in Section 1.3.2.  
 Epigenetic modifications are emerging as critical regulators of drug-related behaviors in 
rodent models. These studies developed from research implicating drug use in widespread 
changes in gene expression and activation of transcription factors (for review, see [52]). Focus 
has shifted from manipulating drug-induced transcription factors, like cAMP response element 
binding protein (CREB) and activator protein 1 (AP-1), to studying how these proteins interact 
with chromatin modifying enzymes to alter gene expression. Studying these epigenetic 
modifications is especially attractive because drug-induced priming of gene promoters may 
underlie long-lasting changes to neurons and glia that promote drug use [53]. 
 While drugs of abuse possess distinct mechanisms, all alter the mesolimbic pathway that 
supplies dopamine to the nucleus accumbens (NAc) and nearly all activate the AP-1 complex in 
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NAc [54,55]; moreover, there is converging evidence that histone modifications play a critical 
role in this modulation. This idea has been especially relevant for acute cocaine exposure, which 
is associated with increased histone acetylation and decreased histone methylation in NAc 
[53,56,57]. Interestingly, both chronic cocaine and morphine decrease dimethylation of lysine 9 
on histone subunit H3 (H3K9me2) and also decrease expression of the histone lysine methyl-
transferase G9a in NAc [53,58]. Additional evidence comes from studies using histone 
deacetylase (HDAC) inhibitors to modify drug-related behaviors. Systemic administration of the 
HDAC inhibitor sodium butyrate enhances locomotor sensitization to ethanol, cocaine, and 
morphine [56,59] and blocks anxiety-related behaviors during ethanol withdrawal [60]. Histone 
methyltransferases also appear to play a role in drug sensitivity and show cell-type specificity. 
Modulation of G9a in subpopulations of NAc neurons alters cocaine sensitization and reward as 
well as gene expression that varies between different dopamine receptor neuronal subtypes [61]. 
These studies highlight the potential for modulating drug-induced histone modifications for 
altering drug-related behaviors. 
 Studies of drug-induced effects on DNA methylation are more limited, potentially due to 
the slow induction of this chromatin modification. However, several studies have focused on 
interactions between methyl CpG binding protein 2 (MeCP2) and drug administration. MeCP2 is 
a transcriptional repressor that binds hypermethylated DNA and has recently been implicated in 
maintenance of neuronal plasticity [62]. Mice with a truncated form of MeCP2 were found to be 
more sensitive to ethanol and consume less ethanol in a continuous drinking paradigm [63]. This 
finding parallels a study showing knockdown of MeCP2 in the dorsal striatum decreases cocaine 
intake [64]. Other studies have found changes in DNA methylation at specific gene promoters 
after cocaine, ethanol, and opioid use [65-67], though these results have been more challenging 
 8 
to associate with a behavior. Therefore, while studies are still limited, modulating enzymes 
associated with methylated DNA appears to affect drug consumption in rodents. 
 While ethanol, cocaine, and opioid exposure have all been associated with differential 
expression of hundreds of genes across multiple brain regions [53,57,68-70], drug-induced 
epigenetic modifications that regulate changes in gene expression are only recently emerging. It 
remains to be seen whether a uniform set of chromatin modifying enzymes regulate the structural 
and cellular changes that underlie addiction. 
1.2.3 Intergenerational inheritance 
This section summarizes the field of intergenerational inheritance; a more detailed discussion of 
the potential role of paternal ethanol on offspring behavior is included in Section 1.3.4.  
 Improved tools to study epigenetic modifications and a search for epi-alleles to explain 
missing heritability of complex phenotypes has led to the discovery of heritable epigenetic 
modifications that contribute to offspring phenotype. This idea is especially intriguing because of 
widespread environmentally-induced epigenetic modifications, some of which may become 
encoded in the germ line (for review, see [71]). New insights into how these epi-alleles escape 
epigenetic reprogramming during early embryogenesis and primordial germ cell development are 
emerging [29,72,73]. In particular, whole genome analysis of DNA methylation has identified 
large regions of the genome around intracisternal A particles (IAP) and imprinted genes that 
retain DNA methylation even as neighboring regions are demethylated [29,74,75]. Small RNAs 
retained in gametes are also emerging as mediators of epigenetic inheritance [71,76,77]. While 
detailed mechanisms of epigenetic inheritance are still developing, a large group of rodent 
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studies have now shown that environmental perturbations can produce phenotypic alterations in 
subsequent generations via inheritance of epigenetic modifications. 
 Early experiments of environmentally-induced epigenetic inheritance in rodents arose 
from epidemiological studies in humans, which show that parental and grandparental nutritional 
status can influence metabolism and longevity of offspring [78-80]. Rodent studies built on these 
findings and allow for rigorous control of genetic background while manipulating environmental 
parameters. Additionally, early studies utilized maternal exposures, which may be especially 
powerful because of effects on in utero development and offspring rearing long after exposure 
has stopped. Maternal obesity appears to have the most pronounced effect of parental nutritional 
changes, with metabolic changes in offspring present through three generations [81,82]. 
Interestingly, both small RNAs and DNA methylation have been proposed to mediate these 
effects [82-84]. Maternal reproductive toxins alter offspring development as well. Administering 
the antiandrogenic pesticide vinclozolin to gestating female rats during primordial germ cell 
development in utero results in male offspring with impaired fertility for three subsequent 
generations [85]. Preconception maternal ethanol exposure may also act as a teratogen, as 
offspring of these dams show an increased rate of skull deformities and changes in DNA 
methylation at an IAP regulating coat color [86]. 
 Paternal exposures provide a more direct way of studying epigenetic inheritance, since 
sires are not present during offspring rearing and in vitro fertilization can eliminate any 
contribution of the sire apart from its germ cell. An early study found that paternal low protein 
diet after weaning was associated with aberrant gene expression and DNA methylation at several 
metabolically relevant loci in offspring [87]. Paternal fasting and high fat diet have both been 
associated with altered glucose metabolism in offspring [88,89]. Paternal folate deficiency was 
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recently found to influence offspring brain development, including levels of methylated cytosine 
[90]. Interestingly, perturbations to the paternal environment may influence maternal investment 
in offspring care, a concept termed maternal provisioning. For example, offspring of sires 
exposed to social enrichment were licked and nursed more frequently than those of sires raised in 
isolation [91]; along these lines, some paternal effects on offspring phenotypes disappear after in 
vitro fertilization [92]. 
 Studies have now extended beyond preconception nutritional exposures to study how 
manipulations of parental behavior alter offspring development. An early study noted that 
maternal licking behavior during the early postnatal period programs offspring behavior across 
generations and is associated with changes in DNA methylation at the glucocorticoid receptor 
promoter [93,94]. Paternal exposures have been especially prominent in mediating behavioral 
effects in offspring. Paternal chronic stress altered sperm miRNA content and led to blunting of 
the hypothalamic-pituitary-adrenal (HPA) axis in offspring [95]. Paternal olfactory fear 
conditioning enhanced response to conditioned odors in offspring and decreased methylation of 
an olfactory receptor [96]. Sires exposed to social defeat stress had offspring that displayed 
increased anxiety-like behaviors [92]. Studies are now identifying mechanisms of paternal 
exposures on offspring phenotypes. A recent study injected sperm miRNAs from males exposed 
to early life stress in the form of maternal separation and found increased depression-like 
behaviors in offspring [77]. While mechanisms that underlie most effects of paternal exposure on 
offspring behavior are still unknown, they raise questions about whether transmission of epi-
alleles in humans can modify risk for psychiatric disease. 
 Parental exposure to drugs of abuse has now been found to alter drug-induced behavior 
and drug consumption in offspring. Adult offspring derived from dams exposed to pre-
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conceptional morphine had enhanced behavioral sensitivity to morphine and other behavioral 
alterations [97]. Male offspring of cocaine-exposed sires surprisingly displayed a cocaine-
resistance phenotype and increased expression of BDNF in the prefrontal cortex [98]. Studies 
have now extended to cross-drug interactions. Parental methamphetamine exposure enhanced 
cocaine-induced locomotion and reward as well as altered DNA methylation in offspring brains 
[99]. Parental tetrahydrocannabinol (THC) exposure was associated with increased heroin-
seeking and altered heroin withdrawal in offspring [100]. It remains to be seen whether these 
drugs are acting on common pathways to modulate drug-induced signaling in offspring or if their 
effects are specific. Considering complex pathways that regulate drug intake, including roles for 
memory, learning, stress, and reward pathways, it may prove difficult to identify a single 
mechanism driving altered drug preference in offspring following a parental exposure. 
1.2.4 Epigenetic programming during spermatogenesis 
This section summarizes epigenetic modifications in sperm; a more detailed discussion of 
ethanol-induced effects on the male reproductive axis is included in Section 1.3.3.  
 Epigenetic modifications during spermatogenesis are highly plastic and regulated by 
coordinated induction of DNA methylation, histone modifications at developmentally important 
loci, and small RNAs. These systems interact to produce a cell with a compact and 
transcriptionally silent nucleus, minimal RNA content, and a paternal imprinting pattern. 
However, while sperm have historically been viewed as passive carriers of genetic information, 
recent studies have demonstrated the importance of sperm-encoded epigenetic modifications for 
offspring development. 
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 Condensation of sperm chromatin in mammals involves replacement of nearly all (95-
99%) histones with highly basic protamines [101]. In general, protamines facilitate nuclear 
condensation by tightly binding DNA, which provides more efficient delivery of genetic material 
and may protect DNA from damage [101]. Retained histones in mature sperm were largely 
ignored until recently, when it was discovered that histone subunit H3 methylated at either lysine 
4 and/or 27 was associated with several loci important for early embryogenesis [102]. A later 
study took an unbiased approach to characterizing sperm chromatin by measuring DNase 
sensitivity across the genome; regions with higher DNase sensitivity, indicating less compaction 
and therefore likely occupancy by a histone rather than a protamine, were enriched in CTCF 
binding sequences [103]. These observations led to a recent study on the role of histone 
modifications in regulating gene expression in embryos. Perturbing protamine incorporation into 
the sperm nucleosome by blocking poly-ADP riboslyation caused aberrant histone retention and 
altered expression of hundreds of genes in two-cell embryos [104]; this study supports the idea 
that sperm histones are potential mediators of epigenetic inheritance. While mechanisms for 
selecting histone vs. protamine occupancy within the sperm genome are still unknown, 
modifying this process affects offspring gene expression and may lead to altered phenotypes. 
 The paternal genome undergoes specialized encoding of DNA methylation during 
spermatogenesis. In primordial germ cells, DNA is actively demethylated and de novo re-
methylated by DNMT3 enzymes to establish parental imprinting patterns and pluripotency [74]. 
After primordial germ cell development, DNA methylation patterns are maintained during 
spermatogenesis by DNMT1 with limited de novo methylation occurring postnatally [105]. 
While not as plastic as primordial germ cell development, DNA methylation during postnatal 
spermatogenesis is vital to sperm and offspring development. In rodent sires, systemic inhibition 
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of DNA methylation by 5-azacytidine resulted in decreased sperm count, infertility, and a 30-
fold increase in the number of abnormal preimplantation embryos [106]. The role of DNA 
methylation in sperm extends beyond transcriptional repression. Hypomethylated regions of the 
sperm genome are enriched in transcription factor binding sites and mark promoters of genes 
expressed in early embryogenesis [102,107]. Therefore, changes to DNA methylation in sperm 
can affect offspring development and locus-specific effects have begun emerging [108,109]. 
 Sperm RNAs have gained significant attention for their role in gametogenesis and, more 
recently, offspring development. Because the mass of RNA in oocytes (~1 ng per cell) dwarfs 
that of sperm (~10 fg per cell) [110], particular attention has been paid to small noncoding RNA 
(sncRNA) that have regulatory functions beyond serving as a template for translation. Studies 
have now identified tens of thousands of distinct populations of sncRNAs in spermatozoa, 
comprised of miRNAs, piRNAs, tRNAs, and other sequences [111,112]. piRNAs are critical for 
silencing of retrotransposable elements during primordial germ cell development and 
spermatogenesis [113,114]. Studies of epigenetic inheritance have specifically focused on the 
role of miRNAs for modifying offspring development. While an early study found only a 
minimal contribution of sperm miRNAs to zygotes [115], others have found a role for specific 
miRNAs in embryo cleavage [116] and offspring phenotypes [76]. Recent studies have found a 
more general role of altered sperm miRNA populations in heritability of paternally transmitted 
phenotypes [77,95]. Therefore, while sncRNA populations in sperm are complex and only 
recently studied, altering their composition can affect offspring phenotypes. 
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1.3 ETHANOL AND EPIGENETICS 
1.3.1 Ethanol-induced gene expression 
Despite decades of research, a definitive mechanism of ethanol that underlies its addictive 
potential has yet to be uncovered. In particular, ethanol is known to modify several 
neurotransmitter receptors; however, understanding how these receptor systems interact to 
promote AUD has proven challenging (for review, see [117]). A novel strategy for uncovering 
potential mechanisms of ethanol is to study its effects unrelated to its ability to bind neuro-
transmitter receptors. In particular, ethanol alters gene expression in several organ types, 
including brain [118,119], liver [120], and intestine [121]. Gene expression studies have focused 
on networks of genes that may be important in mediating adaptive responses to ethanol; 
however, identifying those genes also permits study of epigenetic modifications that may be 
conserved across gene promoters after ethanol exposure. Studying transcription factors or 
chromatin modifying enzymes that mediate these effects could represent a more robust approach 
to uncovering mechanisms of ethanol that promote AUD. 
 In humans, AUD is associated with differential expression of genes in the amygdala, 
cortex, and hippocampus [119,122-124]. These changes drive neuronal and glial adaptations to 
repeated ethanol exposure that are thought to incentivize further ethanol consumption [125].  
Several whole genome expression studies of AUD using the frontal cortex have now shown 
widespread, though relatively modest (~50%), changes in expression of thousands of genes 
[118,122,124,126]. They have also identified several networks altered by chronic alcohol 
consumption, including genes involved in myelination and neurodegeneration that may underlie 
white matter loss due to AUD [119,124]. While informative, technical issues, like quality of 
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post-mortem tissue and donor history, have made it difficult to compare datasets; for example, 
one study used RNA-seq and found only a few dozen differentially expressed genes in the 
hippocampus of adults with AUD [123]. Studies are now moving past simply identifying genes 
and utilizing whole genome data to uncover mechanisms of gene regulation, including measuring 
miRNA expression and GC content of differentially expressed genes [122,127]. 
 Technical challenges in human studies are overcome using rodent models, where animals 
are tested together and alcohol exposure can be controlled. In rodents, a single, binge-like 
exposure to ethanol is also associated with up- and down-regulation of genes in the cortex, 
nucleus accumbens, and ventral tegmental area [68,69,128]. Changes in gene expression are also 
associated with compensatory changes in miRNA regulation [129], suggesting post-translational 
mechanisms that may also underlie escalation of ethanol drinking. Gene expression microarrays 
have also been used to identify genes conferring altered preference for ethanol between different 
strains [128,130]. These studies have culminated in the identification of a mutation in a 
metabotropic glutamate receptor that confers increased alcohol preference in rats [131]. While 
rodent studies have had greater success identifying genes that confer risk for alcohol drinking 
compared to human gene expression analyses, few have examined mechanisms of ethanol-
induced gene regulation. 
1.3.2 Ethanol-induced epigenetic modifications in the brain 
Studies are emerging on epigenetic mechanisms that regulate ethanol-induced changes to gene 
expression. Two studies using post-mortem tissue from people with AUD identified altered 
distribution of histone trimethylation in the hippocampus and cortex, which corresponded to 
gene expression changes in these regions [122,123]. Additionally, dysregulation of miRNAs, 
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retrotransposable elements, and DNA methylation have been discovered in similar post-mortem 
tissue [122,127]. Research has now extended to using pharmaceuticals with epigenetic 
mechanisms for treatment of AUD. The HDAC inhibitor valproic acid has been studied as a 
potential therapeutic and was found to reduce relapse rates [132] and alcohol drinking [133] in 
small cohorts of patients. While still limited, these studies suggest a role for epigenetic 
modifications in the maintenance of AUD. 
Histone Modifications Brain Region Role Reference 
H3K9ac and H3K9me2 
Primary 
Neuronal Cell 
Culture 
↑H3K9ac and ↓H3K9me2 underlie 
↑NR2B expression after CIE 
Qiang et al. 
[134] 
H3K9ac, H3K4me3, 
andH3K27me3 Amygdala 
Chronic ethanol alters histone 
modifications at prodynorphin and 
pronociceptin promoters 
D'Addorio 
et al. [135] 
pan-H3 acetylation and 
H3K4me3 Hippocampus 
Chronic ethanol alters histone 
modifications at Bdnf exons in 
hippocampus 
Stragier et 
al. [136] 
pan-H3 and H3K9 
acetylation 
Central Nucleus 
of Amygdala 
Histone acetylation underlies ethanol 
preference differences between P and 
NP rats 
Moonat et 
al. [137] 
pan-H3 and H4 
acetylation 
Prefrontal 
Cortex 
Histone acetylation underlies  
conditioned place aversion extinction 
in adolescents vs. adults 
Pascual et 
al. [138] 
pan-H3 and H4 
acetylation 
Medial Nucleus 
of Amygdala 
Histone acetylation underlies 
tolerance to the effects of ethanol 
Sakharkar 
et al. [139] 
pan-H3 and H4 
acetylation 
Central Nucleus 
of Amygdala 
Histone acetylation underlies ethanol-
induced anxiolysis and withdrawal-
induced anxiety 
Pandey et 
al. [60] 
pan-H3 and H4 
acetylation 
Ventral 
Tegmental Area 
Altered histone modifications at gene 
promoters following 9 day chronic 
vapor ethanol and withdrawal 
Shibasaki et 
al. [140] 
Table 1. List of histone modifications altered by ethanol in the brain 
  
 Rodent studies of ethanol-induced epigenetic modifications have focused on specific 
brain regions important for regulating ethanol-related behavior (Table 1). Acute ethanol has now 
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been associated with increased histone acetylation in the central nucleus of the amygdala [60], 
altered histone modifications at the prodynorphin and pronociceptin promoters in the amygdala 
[135], and altered expression of histone modifying enzymes in the striatum and prefrontal cortex 
[141]. Chronic ethanol consumption was recently associated with increased expression of Bdnf in 
the hippocampus and ethanol-induced histone modifications at the Bdnf promoter [136]. 
Modulating histone modifications appears to have a dramatic effect on ethanol-related behaviors. 
Systemic administration of the HDAC inhibitor sodium butyrate blocked ethanol-induced 
behavioral sensitization, indicating histone deacetylation plays a critical role in the neuroadaptive 
response to ethanol administration [142]. Systemic HDAC inhibition also blocked the effects of 
ethanol withdrawal by reducing anxiety-like behaviors and increasing expression of Bdnf, Arc, 
and Npy in the amygdala [60,139,143,144]. Specific HDACs are being implicated in regulating 
ethanol drinking and withdrawal. A recent study pointed to HDAC2 expression in the amygdala 
as a critical regulator of ethanol preference and anxiolytic response to acute ethanol [137]. All of 
these studies provide evidence that ethanol-induced histone modifications in the brain are critical 
regulators of ethanol-related behaviors and consumption in rodents. 
 Despite emerging evidence for the role of histone modifications in mediating the effects 
of ethanol, only the HDAC2 studies have attempted to correlate changes in gene expression with 
ethanol-induced changes to histone modifying enzymes. Additionally, there have been no 
unbiased, genome-wide studies of histone occupancy after ethanol exposure using a rodent 
model. These studies will provide mechanistic insight into the well-established effects of ethanol 
on gene expression; additionally, they could identify networks of transcription factors induced by 
ethanol based on DNA sequences associated with altered histone modifications.  
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1.3.3 Ethanol-induced epigenetic modifications in gametes 
Ethanol has notable effects on the male reproductive axis, including altering how epigenetic 
modifications are programmed in germ cells. In humans, research has mainly focused on 
potential effects of alcohol consumption on fertility. In general, while moderate alcohol 
consumption has limited effects on fertility parameters [145,146], several studies have noted 
abnormalities in sperm morphology among men with AUD and/or high alcohol consumption (for 
review, see [147]). The effects of chronic alcohol on fertility are thought to be mediated in part 
by central hypogonadism in men with AUD, leading to decreased circulating testosterone levels 
and altered testicular physiology [148,149]. Additionally, spermatogenesis may be especially 
susceptible to aberrant one carbon metabolism after chronic alcohol use, in particular alcohol-
induced deficits in s-adenosylmethionine (SAM) [150,151], though no studies have examined 
DNA methylation in spermatocytes of men with AUD. A recent study in men with moderate 
alcohol consumption found a trend for hypomethylation of paternally imprinted genes in those 
who consumed alcohol compared to those who did not drink alcohol [152]. No studies have 
examined whether RNA and histone modifications are altered by AUD in spermatocytes, which 
will yield further information on potential effects on offspring development. 
 Rodent studies have focused on mechanistic aspects of ethanol-induced effects on the 
reproductive axis. In particular, studies are able to use a range of ethanol exposures that are 
difficult to replicate in humans. Two weeks of ethanol injections were found to decrease sperm 
counts and plasma testosterone as well as increase oxidative stress in mice [153]. Increased 
oxidative stress has been associated with global DNA hypomethylation in human sperm [154], 
suggesting a role for oxidative stress in ethanol’s effects on sperm DNA methylation. Ethanol 
gavage 3 times per week for nine weeks in rats was associated with decreased expression of 
 19 
DNMT1 in sperm [155]. Studies have focused on the effect of ethanol consumption on DNA 
methylation at heavily methylated, imprinted regions in sperm that are resistant to genomewide 
demethylation. One study did not find changes in sperm one week after ethanol exposure but 
noted significant hypomethylation at paternally imprinted regions in the offspring of ethanol-
exposed sires [156]. Another study found hypomethylation at one of these paternally imprinted 
regions in sperm after four weeks of ethanol treatment [157].  
1.3.4 Effects of paternal ethanol exposure on offspring 
The effects of ethanol on multiple aspects of the male reproductive axis discussed in Section 
1.3.3 suggest that ethanol is altering sperm development. Moreover, as emerging evidence points 
to a role of the sperm epigenome and microenvironment in offspring development (see Section 
1.2.3), these ethanol-induced effects on sperm development are likely to have implications for 
children of men with AUD. There are several studies that support an association between fathers 
with AUD and changes across multiple cognitive domains in their offspring. These have shown 
increased risk for psychiatric disorders [158,159], decreased performance on measures of 
intelligence [160], personality changes [160,161], and increased incidence of attention deficit 
hyperactivity disorder (ADHD) [162] in children of men with AUD. Some of these effects are 
specific to fathers who had active AUD compared to those who were in remission [159]. 
Physiological deficits in offspring of alcoholic fathers have also been noted, including 
electroencephalographic changes [163], neuroimaging findings [164], and decreased intracranial 
volumes [165]. In particular, decreased amplitude of the P300 event related potential (ERP) has 
been associated with AUD and shows evidence for inheritance [163,166]. While these results are 
confounded by social and environmental factors associated with being raised by a father with 
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AUD, they also raise the possibility that acquired changes to male gametes are being transmitted 
to offspring. 
 Based on human studies that show a role for paternal ethanol on offspring development, 
rodent studies have used controlled alcohol exposures to study these effects in depth. Most of 
these animal studies have been undertaken from a fetal alcohol syndrome (FAS) perspective, 
which posits that parental ethanol use induces a spectrum of morphological and cognitive deficits 
in offspring. In rodents, paternal ethanol induces physiological abnormalities in offspring in the 
absence of maternal ethanol exposure, including low birth weight [155,167], increased number 
of runts [155], altered organ weights [167,168], thickening of layers of the cerebral cortex [169], 
and low testosterone levels [170]. Several behavioral abnormalities have also been noted, 
including decreased spatiotemporal learning [171], decreased novelty seeking behavior [167], 
increased immobility on the forced swim test [172], and decreased grooming [173]. More recent 
studies have found decreased open arm entries on the elevated plus maze [157] and increased 
impulsivity [174] in offspring of ethanol-exposed sires. One of these groups found altered 
expression of DNMT1 and MeCP2 in brains of paternal ethanol-sired offspring [174], suggesting 
potentially widespread epigenetic abnormalities in these animals. While these effects are varied, 
it is important to note that animals show deficits in some but not all behaviors, suggesting 
paternal ethanol affects discrete neurobiological pathways. Moreover, conserved changes in 
behavior across multiple animals would be challenging to explain by random mutations in the 
sperm genome. Unfortunately, gene-specific alterations in mice sired by alcohol-exposed fathers 
are still lacking, though improved methodology to study epigenetic modifications may lead to 
their identification in the future.  
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Despite the range of effects reported for paternal ethanol exposure on offspring, no 
groups have studied its effects on ethanol-induced behaviors or ethanol drinking. With the 
emergence of several groups reporting intergenerational inheritance of drug seeking behavior, it 
is possible epi-alleles account for the heritability of AUD. 
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1.4 HYPOTHESIS AND SPECIFIC AIMS 
Despite its ubiquitous use and access, knowledge of basic neurobiological mechanisms of 
ethanol remains limited, delaying the development of pharmacological treatments for alcoholism. 
Moreover, GWAS has accounted for only a fraction of a percent of the heritability of AUD, 
delaying identification of individuals at high risk for alcohol dependence. To test the hypothesis 
that epigenetic modifications contribute to neurobiological mechanisms of ethanol and 
heritability of AUD, I developed three specific aims:  
• Specific Aim 1 tests the hypothesis that paternal preconception ethanol exposure alters 
ethanol consumption and response to ethanol in offspring. 
• Specific Aim 2 tests the hypothesis that conserved histone modifications regulate 
ethanol-induced gene expression in the cerebral cortex. 
• Specific Aim 3 develops a method for studying histone modifications in a neuronal 
subtype in vivo and tests the hypothesis that chronic intermittent vapor ethanol and 
withdrawal induce dynamic changes in gene regulation via discrete histone modifications 
in accumbal dopamine 1 receptor positive medium spiny neurons. 
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2.0  PATERNAL ETHANOL ALTERS OFFSPRING BEHAVIOR 
Adapted from: Finegersh A, Homanics GE (2014) Paternal Alcohol Exposure Reduces Alcohol 
Drinking and Increases Behavioral Sensitivity to Alcohol Selectively in Male Offspring. PLoS 
ONE 9(6): e99078. [175] 
2.1 INTRODUCTION 
Although the heritability of AUD is estimated to be ~50% among men [9], the genetic basis for 
this disease is poorly understood despite considerable scientific investment. Like many other 
complex, polygenic diseases, DNA sequence variations are associated with risk of acquiring 
AUD [24,25]; however, these variants account for a tiny fraction of the total risk [23].  
 Emerging evidence from several converging fields has reinvigorated the idea that 
inheritance of acquired characteristics, “epigenetic inheritance,” is an adjunct to traditional 
modes of genetic inheritance. In rodent studies in which genetics and environment can be 
rigorously controlled, it is now established that environmental perturbations can produce 
phenotypic alterations in subsequent generations without further exposures. For example, in 
isogenic rodents, exposure to stress [77,95], endocrine disruptors [85], high fat diet [89], low 
protein diet [87], and olfactory fear conditioning [96] all result in phenotypic changes in 
subsequent generations. There is also a growing literature on intergenerational effects of drugs of 
abuse. Adult offspring derived from dams exposed to morphine prior to conception displayed 
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enhanced behavioral sensitivity to morphine and other behavioral alterations [97].  Male 
offspring of cocaine-exposed sires surprisingly displayed a cocaine-resistance phenotype [98]. 
Finally, prenatal exposure to ethanol was associated with transgenerational effects on POMC 
expression that was inherited through the male germ line [176]. 
A number of studies support the idea that parental ethanol exposure prior to mating can 
alter the phenotype of offspring. In rodents, paternal preconception ethanol exposure induced 
developmental abnormalities including altered organ weights including brain [168,177], 
thickening of cortical layers [169], and decreased testosterone levels [170]. Paternal ethanol 
exposure also induced numerous behavioral abnormalities, including decreased grooming 
behavior in response to novelty or water immersion [173], altered spatial learning [167], 
decreased novelty seeking [171], and decreased immobility in a forced swim test [172]. These 
changes did not appear to be related to stress or undernutrition associated with ethanol exposure. 
The studies cited above led us to hypothesize that ethanol drinking behavior and 
neurobiological sensitivity to ethanol are due in part to paternal ethanol exposure prior to 
conception. To test this hypothesis in a model system that was free from confounding genetic 
and environmental influences, adult male mice were chronically exposed to ethanol (or control 
conditions) and subsequently mated to ethanol naïve females. Adult offspring were tested for 
ethanol drinking on the two bottle choice test and drinking in the dark assays as well as a range 
of ethanol-induced and basal behaviors. 
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2.2 MATERIALS AND METHODS 
2.2.1 Animals 
All experiments were approved by the Institutional Animal Care and Use Committee of the 
University of Pittsburgh. Eight-week-old, ethanol-naïve, specific pathogen free C57BL/6J and 
Strain 129Sv/ImJ mice were purchased from Jackson Laboratory (Bar Harbor, ME) and used to 
generate the F1 generation of offspring as described below. Mice were group-housed under 12 
hour light/dark cycles and had ad libitum access to food and water. 
2.2.2 Paternal ethanol exposure 
Vapor ethanol inhalation was used because it allows for ad libitum access to food and water, no 
stress-inducing injections or gavage, and animals remaining in their home cage. Two identical 
custom-built vapor chambers were used (16” x 16” x 24” constructed from 0.5” plexiglass) to 
deliver either room air or vaporized ethanol. Flow rate, vaporization temperature, and exposure 
time were optimized to achieve consistent blood ethanol concentrations (BEC) without the use of 
pyrazole. Room air was flowed into two heated Erlenmeyer flasks at a rate of 8 L/min; one flask 
received ethanol at a rate of ~250 μl/min while the other flask received no ethanol. Air from the 
ethanol and control flasks flowed into separate chambers so that only one chamber received 
vaporized ethanol. 
 Male C57BL/6J mice were placed in vapor chambers from 08:00 to 16:00 for 5 
consecutive days/week for at least 5 weeks. Five weeks of exposure was chosen because it 
represents a complete cycle of murine spermatogenesis [178]. Temperature of the chambers was 
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monitored daily and averaged 78˚ F at the end of 8 h of exposure. Mice were weighed at the 
beginning of each week and blood was collected from the tail vein at the end of each week. Total 
ethanol in plasma was measured using an Analox ethanol analyzer (AM1, Analox Instruments, 
London, UK). 
2.2.3 Breeding scheme and offspring rearing 
Immediately following the final day of exposure, male mice were removed from group housing 
and housed with two eight-week-old, ethanol-naïve Strain 129Sv/ImJ female mice. Strain 
129Sv/ImJ females were chosen because they do not erase epigenetic marks at intracisternal A 
particles (IAPs) in offspring in utero while C57BL/6J females do erase these marks [108]. After 
48 hours, males were removed from the females’ cages. Strain 129xC57 F1 hybrid offspring 
were reared normally and weighed weekly beginning at 3 weeks of age. All offspring used in 
behavioral experiments were at least 8 weeks of age. 
2.2.4 Isolation of motile sperm DNA 
Male mice were group housed and exposed to vapor ethanol or room air for an additional 3 days 
following mating. This additional exposure was done so that ethanol-induced epigenetic marks 
were not lost during this time period and that the effects of ethanol withdrawal on gene 
expression and epigenetic processes would not affect germ cells. Sixteen hours following 
exposure, the cauda epididymis was dissected from the testes and placed into 4 ml of 1% bovine 
serum albumin (BSA) in PBS. Sperm and DNA were extracted using a double swim up assay as 
previously described [179]. Briefly, several longitudinal cuts were made through the cauda 
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epididymis using a scalpel and the tissue in 1% BSA was collected into a 15 ml conical tube. The 
tissue was incubated for 30 minutes at 37˚ C and the top 2 ml of liquid was collected into a new 
15 ml conical tube, which was incubated for an additional 15 minutes at 37˚ C. The top 1 ml 
containing motile sperm was collected and used for analysis. Sperm were pelleted at 6000 rpm 
for 5 min at 4˚ C, resuspended in sperm lysis buffer with proteinase K [179], and incubated at 
50˚ C overnight. DNA was extracted using a phenol-chloroform-isoamyl alcohol extraction and 
an ethanol precipitation and eluted in 100 μl TE buffer. 
2.2.5 Isolation of RNA and DNA from the VTA and mPFC 
Adult offspring were sacrificed by cervical dislocation and the brain extracted and placed into an 
ice cold adult mouse brain slicer matrix with 1 mm coronal section slice intervals (Zivic 
Instruments, Pittsburgh, PA). Razor blades were inserted starting at the rostral end through the 
midbrain. The ventral tegmental area (VTA) was collected on the first slice where the hippo-
campus wrapped around the midbrain as the region medial to the substantia nigra. The medial 
profrontal cortex (mPFC) was collected on the first two consecutive slices where the cortex was 
first visible. These structures were collected, flash frozen in liquid nitrogen, and stored at -80˚ C. 
RNA and DNA were extracted using Trizol (Life Technologies, Carlsbad, CA) according to the 
manufacturer’s protocol. RNA was purified using the RNeasy mini kit with DNase digestion 
(Qiagen, Valencia, CA) and eluted in 30 μl water. DNA was eluted in 100 μl TE buffer. 
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2.2.6 Bisulfite sequencing 
Bisulfite treatment was carried out using the EZ DNA Methylation-Gold Kit (Zymo Research, 
Irvine, CA) according to the manufacturer’s protocol. Briefly, 20 μl of DNA in TE buffer was 
treated with sodium bisulfite, desulphonated, and eluted in 10 μl of water. Bisulfite-treated DNA 
was used as a template for a nested PCR reaction. Primer sequences used are summarized in 
Table 1. PCR conditions for the outside reaction were: 4 min at 94˚ C, 2 min at 55˚ C, and 2 min 
at 72˚ C repeated once then 1 min at 94˚ C, 2 min at 55˚ C, and 2 min at 72˚ C repeated 35 times. 
The outside reaction was used as a template for the inside reaction, whose conditions were: 4 
min at 94˚ C, then 1 min at 94˚ C, 2 min at 55˚ C, and 2 min at 72˚ C repeated 35 times, then 7 
min at 72˚ C. The inside PCR reaction was run on a 1.2% agarose gel and a ~300 bp product 
excised and gel purified using the Purelink Quick Gel Extraction kit (Life Technologies) 
according to the manufacturer’s protocol. Gel-purified PCR products were cloned into a TOPO 
TA vector (Life Technologies) according to the manufacturer’s protocol and transformed into 
TOP10 competent cells (Life Technologies). Cells were plated onto LB agar plates with 
ampicillin. Individual colonies were selected and grown overnight separately in LB with 
ampicillin, then plasmids were purified using the QIAprep Spin Miniprep Kit (Qiagen) according 
to the manufacturer’s protocol. 
 Plasmids were checked for the presence of an insert using an EcoRI digestion. Those 
with an insert were sent for sequencing (Genewiz, South Plainfield, NJ). After sequencing, trace 
files and the original BDNF exon IXa CpG island, IG DMR, or H19 DMR sequence were loaded 
into CpGviewer, an automated bisulfite sequencing analysis program that detects the methylation 
status of potentially methylated cytosines [180], and results were used for analysis. At least two 
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separate bisulfite treatments for each animal’s tissue were performed and at least four animals 
per group were used for analysis. 
 
Table 2. Primer sequences for bisulfite sequencing reactions 
2.2.7 Reverse Transcription Quantitative PCR (RT-qPCR) 
300 ng of RNA was converted into cDNA using reverse transcriptase (RT) (Bio-Rad, Hercules, 
CA). Reactions were carried out in duplicate for each gene. SYBR green fluorescent master mix 
(Bio-Rad) was added to each well and visualized using a Bio-Rad iCycler. All primers were 
optimized for 90% to 110% efficiency at the following conditions: 10 min at 95˚C followed by 
40 cycles of 30 s at 95˚C, 1 min at 60˚C, and 30 s at 72˚C. Primer sequences used are 
summarized in Table 2. Threshold cycle (Ct) values were calculated for each well and duplicate 
values averaged. The difference between specific genes and β-actin (ΔCt) was calculated for 
each animal and normalized to the average of room air sired offspring (ΔΔCt). Fold change over 
room air sired offspring was calculated for each animal using the following formula: 2-ΔΔCt. 
Amplicon Forward primer (5'-->3') Reverse primer (5'-->3') 
BDNF exon IV CAGGAGTACATATCGGCCACCA GTAGGCCAAGTTGCCTTGTCCG 
BDNF exon Ixa AGCCTCCTCTACTCTTTCTGCTG GTGCCTTTTGTCTATGCCCCTG 
Dlk1 GGCCATCGTCTTTCTCAACA ATCCTCATCACCAGCCTCCT 
β-actin TCATGAAGTGTGACGTTGACATCCGT CCTAGAAGCATTTGCGGTGCACGATG 
Table 3. Primer sequences used for RT-qPCR experiments on offspring 
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2.2.8 Forced Swim Test 
Mice were tested for their performance on the forced swim test, which correlates with anxiety- or 
depression-like behaviors in rodents [181]. Mice were placed into a standard 1000 mL beaker 
filled to 900 mL with 26˚ C tap water. The water level was 10 cm above the bottom of the beaker 
before the mouse was placed into the beaker. Swimming behavior was scored for latency to 
immobility and total immobility after the first 2 minutes for 4 minutes. Immobility was defined 
as a cessation in swimming behavior for greater than 5 seconds. After testing, mice were quickly 
dried with paper towels and placed under a heat lamp for half an hour, then returned to their 
home cage. 
2.2.9 Grooming behavior 
One week following testing for the forced swim test, mice were randomly divided into two 
groups and tested for basal and induced grooming behaviors. For basal grooming, mice were 
removed from their home cage and singly housed in an empty cage. After acclimating to the new 
cage for 15 minutes, grooming behavior was measured for 5 minutes and scored for latency to 
groom, frequency of grooming episodes, and duration of grooming. For induced grooming, mice 
were also acclimated to single housing in a new cage for 15 minutes. Then, they were placed on 
top of the new cage and gently sprayed twice with water on the dorsal surface from a distance of 
~2 inches. They were placed back in their cage and scored for latency to groom, frequency of 
grooming episodes, and duration of grooming over 5 minutes. 
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2.2.10 Two bottle choice 
The two bottle choice test was used to assess the effect of paternal ethanol exposure on ethanol 
preference and consumption. Mice were acclimated to individual housing with food available ad 
libitum for one week. After one week, water bottles were replaced with two modified 25 ml 
polystyrene serological pipets (Thermo Fisher, Waltham, MA) fitted with ball bearing sipper 
tubes and filled with drinking water. Every 4 days, mice were weighed, total volume consumed 
measured by reading volume markers on the tubes, and tubes were removed, washed, and 
replaced. After 4 days of drinking water, tubes were replaced with one tube containing a 3% 
(w/v) ethanol solution and the other containing drinking water. This was immediately followed 
by 4 days each of a choice between 6%, then 9%, then 12%, and then 15% ethanol solutions and 
drinking water. The position of the ethanol tube was changed every 4 days, and there were no 
mice exhibiting a side preference for either tube position. A subset of mice was also tested for 
their preference for saccharin (0.033% and 0.066% w/v) then quinine hemisulfate (0.03 and 0.06 
mM) following 15% ethanol solution. There was a 1 week washout period between ethanol, 
saccharin, and quinine tastants where both tubes contained water. Quantity of ethanol, saccharin, 
quinine, and water consumed was calculated for each mouse (g/kg/day or ml/kg/day) and 
preference was calculated as a ratio of solution consumed over total volume consumed. All 
solutions were also placed in an empty cage for 4 days to determine evaporation and spillage 
estimates, which were subtracted from the total volume consumed of each solution for each 
mouse. 
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2.2.11 Elevated plus maze, open field, and accelerating rotarod 
Offspring were tested for their performance on three consecutive behavioral tests after a single 
intraperitoneal injection with either 1 g/kg ethanol (0.02 ml/g body weight of 5% ethanol in 0.9% 
saline) or 0.02 ml/g 0.9% saline. Prior to injection, mice were individually housed with no food 
or water for 1 hour. 
 The elevated plus maze was used to assess the effect of paternal ethanol exposure on 
basal anxiety-like behavior and ethanol-induced anxiolysis. Ten minutes after injection, mice 
were place in the center of an elevated plus maze facing an open arm. Sessions were video 
recorded for 5 minutes and manually scored for number of arm entries and time spent in each 
arm; arm entries were defined as all four limbs within an arm. At the conclusion of the elevated 
plus maze assay, mice were returned to individual housing. 
 The open field test was used to assess the effect of paternal ethanol exposure on basal and 
ethanol-induced locomotor activity. Five minutes after the conclusion of the elevated plus maze 
(20 minutes post-injection), mice were placed in the corner of a 43.2 x 43.2 x 30.5 cm open field 
box with a white floor and clear plexiglass walls (Med Associates Inc., St. Albans, VT). The 
open field box was placed in a sound attenuating cubical (Med Associates Inc.) and illuminated 
by a 1W bulb and a small fan provided a low level of background noise. Movement was tracked 
using infrared beam sensors over a 10 minute trial. 
 The accelerating rotarod test was used to assess the effect of paternal ethanol exposure on 
basal motor coordination and ethanol-induced ataxia. Five minutes after the conclusion of the 
open field test (35 minutes post-injection), mice were habituated to the rotarod (Ugo Basile, 
Italy) for 30 seconds at 5 rpm. Then, the rotarod was accelerated from 5 to 50 rpm over 180 
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seconds. The amount of time mice remained on the accelerating rotarod was measured for 5 
separate trials spaced 60 seconds apart. 
2.2.12 Drinking in the dark assay 
The drinking in the dark assay is a model of scheduled, limited access ethanol consumption that 
produces elevated BECs in high drinking mouse strains [182]. In this assay, offspring were 
singly housed for one week before testing with ad libitum food and a standard water bottle. 
Beginning on Monday each week, the water bottle was replaced with one 25 ml polystyrene 
serological pipet 3 hours after onset of the dark cycle. For Monday, Tuesday, and Wednesday, 
mice had access to the solution for 2 hours; on Thursday, mice had access to the solution for 4 
hours. At the end of the time period, total volume consumed measured by reading volume 
markers on the tubes and the standard water bottle was placed back in the cage. This experiment 
was completed first with water, then 10% ethanol solution in water the following week, then 
20% ethanol solution in water the following week. Therefore, there was a 3 day washout period 
between each solution. All mice were weighed and cages changed at the beginning of the week. 
2.2.13 Ethanol metabolism 
The rate of ethanol clearance was determined to assess the effect of paternal ethanol on ethanol 
metabolism. Mice were injected with 3.5 g/kg ethanol i.p. (0.02 ml/g of 17.5% ethanol in 0.9% 
saline). Blood was collected by tail nick at 60 minutes and 240 minutes post-injection. Total 
ethanol in plasma and standards was measured using an Analox ethanol analyzer.  
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2.2.14 Statistical analysis 
Behavioral experiments were analyzed using a Student’s t-test, χ2 test, and two-way ANOVA 
with or without repeated measures where appropriate. For ANOVAs, post-hoc pairwise 
comparisons were made using the Fisher’s LSD test. For analysis of DNA methylation, groups 
were analyzed using the Mann Whitney U test. For RT-qPCR data, groups were analyzed using a 
Student’s t-test. Data from mice that differed by 2 SDs from the mean were considered outliers 
and excluded from analysis. All data are presented as mean +/- standard error bars. 
2.3 RESULTS 
2.3.1 Paternal ethanol exposure 
This chronic intermittent vapor ethanol exposure paradigm induces dependence [183] and 
increases voluntary ethanol drinking [184]. Blood ethanol concentrations (BEC) were measured 
weekly on the final day of ethanol exposure and averaged 147.1 +/- 7.52 mg/dl (mean +/- SEM) 
(Fig. 2B). Sires were weighed at the beginning of each week and there was a significant effect of 
time on sire weight over the course of five weeks (F(4,200) = 54.50, p < 0.0001) but no significant 
effect of treatment or interaction, indicating generally normal weight gain among ethanol 
exposed sires (E-sires) compared to control sires (C-sired) (Fig. 2C). 
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 Figure 2. Chronic vapor ethanol exposure 
 (A) 8-week-old C57BL/6J mice were exposed to ethanol vapor or room air for 8 hours/day, 5 
days/week, for 5 weeks and immediately housed with 2 ethanol-naïve Strain 129Sv/ImJ females 
for 48 hours; after mating, they were re-exposed for 3 days and motile sperm was collected. (B) 
Blood ethanol concentrations showed limited variability across 5 weeks and averaged 147.1 +/- 
7.52 mg/dl (mean ± SEM) (n = 25). (C) There was no difference in weight gain between ethanol 
(E-sires) (n = 25) and room air (C-sires) (n = 27) exposed sires during the 5 weeks of exposure. 
2.3.2 Ethanol exposure hypomethylates the IG DMR in motile sperm 
Alcohol consumption was found to decrease DNA methylation of paternally imprinted regions in 
motile sperm [152]; therefore, these regions were studied following the chronic vapor ethanol 
exposure in this study. There was a ~5% reduction in DNA methylation at the intergenic (IG) 
differentially methylation region (DMR) in sperm (p < 0.001), which regulates expression of 
Dlk1 from the paternal chromosome [185] (Fig. 3A,C); however, there was no difference in 
DNA methylation of the H19 DMR, which regulates expression of Igf2 from the paternal 
chromosome [186] (Fig. 3B,D). These results suggest locus-specific changes to DNA 
methylation in motile sperm following chronic ethanol exposure. 
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 Figure 3. Ethanol decreases DNA methylation of the IG DMR in motile sperm 
DNA methylation at the intergenic (IG) and H19 differentially methylated regions (DMR) were 
measured in motile sperm using bisulfite sequencing. (A,C) DNA methylation is significantly 
reduced at the IG DMR in motile sperm of ethanol-exposed sires relative to room air controls. 
(B,D) There is no change in DNA methylation of the H19 DMR following ethanol exposure. Each 
circle represents a potentially methylated cytosines in the DMR; filled circles are methylated and 
unfilled circles are unmethylated. Each block of rows represents sequenced colonies from a single 
independent animal. n = 6-7/group. Data presented as mean ± SEM. *p < 0.0001. 
 
2.3.3 Paternal ethanol increases male offspring weight in 129xC57 offspring 
Immediately following the 5th week of exposure, each sire was mated to 2 ethanol-naïve Strain 
129Sv/ImJ females for 48 hours; there was no significant difference in the number of offspring 
sired or litter size from E-sires compared to C-sires (Fig. 4A-B). For body weight of male 
offspring, there was a significant effect of time (F(3,297) = 900.7, p < 0.0001) and sire exposure 
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(F(1,99) = 17.35, p < 0.0001) but no interaction of time and treatment; post-hoc analysis revealed 
that E-sired male offspring weighed more than C-sired male offspring at four (p < 0.01), five (p 
< 0.001), and six weeks (p < 0.01) of age (Fig. 4C). For body weight of female offspring, there 
was a significant effect of time (F(3,258) = 508.3, p < 0.0001), but no effect of sire exposure or 
interaction between time and treatment (Fig. 4D). 
 
Figure 4. Litter characteristics of ethanol-exposed sires 
(A) There were no differences in number of litters, number of male and female offspring, or (B) 
number of offspring per litter between E- and C-sires. (C) E-sired male offspring (n = 40) gained 
significantly more weight after weaning at 3 weeks and maintained increased weight through week 
6 compared to C-sired male offspring (n = 61) (p < 0.001). (D) There was no significant difference 
in weight between E- (n = 43) and C-sired (n = 45) female offspring. Note: Error bars in C and D 
are obscured by the data points), **p < 0.01, ***p < 0.001. 
2.3.4 Paternal ethanol on forced swim test behavior 
Mice were tested forced swim behavior based on studies showing an effect of paternal ethanol on 
this assay [172,187]. There was a significant effect of sex on latency to immobility (F(1,31) = 
17.04, p < 0.001) as well as a trend for sire exposure (F(1,31) = 3.10, p = 0.08) and a trend for an 
interaction between sex and sire exposure (F(1,31) = 3.46, p = 0.07) (Fig. 5A); post-hoc analysis 
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revealed E-sired females had increased latency to immobility compared to C-sired females (p < 
0.05). There was a near-significant trend for an effect of sex on total immobility (F(1,31) = 4.03, p 
= 0.053) but no effect of sire exposure or interaction between sex and sire exposure (Fig. 5B). 
 
Figure 5. Paternal ethanol on forced swim test behavior 
(A) Female offspring of sires exposed to ethanol (E-sired) had significantly increased latency to 
immobility compared to control-sired female offspring (C-sired); there were no significant effects 
between E- and C-sired male offspring. (B) There were no significant effects between E- and C-
sired offspring on total immobility. n = 9/group; *p < 0.05. 
2.3.5 No effect of paternal ethanol on grooming behavior 
There were no significant effects of sex or sire on basal grooming or induced grooming 
following misting with water, suggesting no effect of paternal ethanol on grooming (Fig. 6). 
 
Figure 6. No effect of paternal ethanol on grooming behavior 
There was no effect of paternal ethanol on (A) basal or (B) induced grooming. 
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2.3.6 Paternal ethanol reduces ethanol consumption in male offspring 
Offspring were tested for ethanol preference and consumption versus water using a standard two 
bottle choice drinking paradigm. Singly-housed mice were tested sequentially for consumption 
of 3%, 6%, 9%, 12%, and 15% ethanol (w/v%) for 4 days each. For ethanol preference in male 
offspring, there was an effect for sire exposure (F(1,32) = 7.22, p < 0.05) but not for ethanol 
concentration and no interaction between sire exposure and concentration; post-hoc analysis 
revealed E-sired male offspring had significantly decreased preference for 3% (p < 0.05), 6% (p 
< 0.05), and 9% (p < 0.05) ethanol solutions compared to C-sired male offspring (Fig. 7A). For 
ethanol consumption, there was a significant effect of sire exposure (F(1,32) = 6.63, p < 0.05) and  
 
Figure 7. Paternal ethanol on two bottle free choice ethanol drinking 
Offspring were tested for ethanol consumption vs. water on a 2 bottle, free choice drinking assay. 
(A) E-sired male offspring (n = 17) had significantly decreased preference for ethanol compared to 
C-sired male offspring (n = 17) as well as (B) decreased ethanol consumption and (C) no change 
in total volume consumption per body weight. There were no significant differences between E-
sired female offspring (n = 12) and C-sired female offspring (n = 12) on (D) ethanol preference, 
(E) ethanol consumption, or (F) total volume consumed. *p < 0.05, **p < 0.01. 
 40 
ethanol concentration (F(4,128) = 27.82, p < 0.0001) but no interaction; post-hoc analysis revealed 
E-sired male offspring consumed significantly less of 9% (p < 0.05) and 12% (p < 0.01) ethanol 
solutions compared to C-sired male offspring (Fig. 7B). There was no effect of sire exposure, 
ethanol concentration, or interaction on total volume consumed (Fig 7C). 
 For females, there was an effect of ethanol concentration on preference (F(4,88) = 4.84, p 
< 0.01; Fig. 7D), consumption (F(4,88) = 67.63, p < 0.0001; Fig. 7E), and total volume 
consumed (F(4,88) = 4.01, p < 0.01; Fig. 7F).  However, there were no effects of sire exposure 
and no interaction of sire exposure with concentration on any parameter measured. 
 
Figure 8. Paternal ethanol on two bottle choice saccharin and quinine drinking 
There were no significant differences between E- (n = 11) and C-sired (n = 10) male offspring on 
(A) quinine drinking or (B) saccharin drinking; there were also no significant differences between 
E- (n = 6) and C-sired (n = 5) female offspring on (C) quinine drinking or (D) saccharin drinking. 
 
 To investigate if any observed changes in ethanol drinking behavior were influenced by 
alterations in taste perception, mice were tested for preference of quinine or saccharin versus 
water in a similar two bottle choice assay. No effects of sire exposure, concentration, or 
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interaction were observed for males consuming quinine (Fig. 8A) or saccharin (Fig. 8B) or for 
females consuming quinine (Fig. 8C) or saccharin (Fig. 8D). 
2.3.7 No effects of paternal ethanol on the drinking in the dark assay 
Offspring were tested for their ethanol consumption on a scheduled, limited access assay, where 
they had access to ethanol for 2 hours (days 1 through 3) or 4 hours (Day 4). There were no 
significant effects of sire exposure or an interaction between sire exposure and time in either 
male or female offspring on this assay (Fig. 9). 
 
Figure 9. Paternal ethanol on ethanol drinking in the dark 
Offspring were tested on a scheduled, limited access drinking model. There were no significant 
differences in (A,D) water, (B,E) 10% ethanol, or (C,F) 20% ethanol in male or female offspring. 
n = 6-9/group 
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2.3.8 Paternal ethanol effects on the elevated plus maze 
A separate group of ethanol naïve offspring were tested for performance on the elevated plus 
maze (EPM) 10 minutes after treatment with 1 g/kg ethanol or saline i.p.. For male offspring, 
there was a significant effect of treatment (F(1,20) = 5.50, p < 0.05) and sire exposure (F(1,20) = 
7.95, p < 0.05) as well as a significant interaction between treatment and sire exposure (F(1,20) = 
7.21, p < 0.05) on percent time spent in open arms; post-hoc analysis revealed E-sired male 
offspring treated with ethanol spent significantly more time in the open arms compared to those 
treated with saline (p < 0.01) as well as C-sired male offspring treated with ethanol (p < 0.001) 
(Fig. 10A). There was also a significant interaction between treatment and sire exposure (F(1,20) = 
4.97, p < 0.05) on percent of open arm entries relative to total arm entries; post-hoc analysis 
revealed E-sired male offspring treated with ethanol had a significantly greater percent of open 
arm entries compared to those treated with saline (p < 0.01) as well as C-sired male offspring 
treated with ethanol (p < 0.01) (Fig. 10B). These results demonstrate that although basal levels of 
anxiety-like behavior did not differ between groups, male mice born to ethanol-exposed sires 
were more sensitive to the anxiolytic effect of ethanol. 
There was also a significant effect of treatment (F(1,20) = 5.91, p < 0.05) but not sire 
exposure on total arm entries; post-hoc analysis revealed E-sired male offspring treated with 
ethanol made significantly more arm entries compared to those treated with saline (p < 0.05) as 
well as C-sired male offspring treated with ethanol (p < 0.01) (Fig. 10C). These results 
demonstrate that although basal levels of locomotor activity on the EPM did not differ between 
groups, male mice born to ethanol-exposed sires were more sensitive to the stimulatory effects of 
ethanol compared to male mice born to sires that were not exposed to ethanol. 
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For female offspring, there was no significant effect of treatment or sire exposure and no 
interactions for percent time spent in open arms (Fig. 10D). There was a significant effect of 
treatment (F(1,22) = 4.56, p < 0.05) but no effect of sire exposure or interaction on number of open 
arm entries (Fig 10E). There was no significant effect of treatment or sire exposure and no 
interactions for total arm entries (Fig. 10F). 
 
 
Figure 10. Paternal ethanol on the elevated plus maze assay 
Offspring were tested for ethanol-induced anxiolysis by testing performance on an elevated plus 
maze 10 minutes after i.p. injection of 1 g/kg ethanol or saline. (A) E-sired male offspring spend 
greater time in open arms after treatment with ethanol compared to C-sired male offspring and E-
sired male offspring treated with saline; E-sired male offspring treated with ethanol also have (B) 
increased percent of open arm entries and (C) total arm entries relative to C-sired male offspring 
and E-sired male offspring treated with saline. There were no significant differences between E- 
and C-sired females treated with ethanol or saline on (D) time spent in open arms, (E) percent 
open arm entries, or (F) total arm entries. n = 6-7/group, *p < 0.05, **p < 0.01, ***p < 0.001. 
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2.3.9 No effect of paternal ethanol on open field performance 
Five minutes after the completion of the EPM (i.e., 20 minutes after treatment with either 1 g/kg 
ethanol or saline), the same mice were placed in an open field activity monitor and distance 
traveled was measured for 10 minutes. For male offspring, there was a trend for treatment (F(1,24) 
= 3.152, p = 0.09) but no effect of sire exposure or interaction on distance traveled (Fig. 11A). 
For female offspring, there was no significant effect for treatment, sire exposure, or interaction 
on distance traveled (Fig. 11B). 
 
Figure 11. Paternal ethanol on open field performance 
Offspring were tested for locomotor activity in an open field 20 minutes after i.p. injection of 1 
g/kg ethanol or saline. There were no significant differences among (A) E- and C-sired male 
offspring or (B) female offspring after treatment with ethanol. n = 7-8/group. 
2.3.10 Paternal ethanol effects on accelerating rotarod 
Five minutes after completion of the open field test (i.e., 35 minutes after treatment with 1 g/kg 
ethanol or saline), the same mice were tested on five consecutive trials for their ability to remain 
on an accelerating rotarod. For E-sired male offspring, there was a significant effect of trial 
(F(4,56) = 5.93, p < 0.001), a  trend of treatment (F(1,14) = 3.21, p = 0.09), and a significant 
interaction between trial and treatment (F(4,56) = 2.86, p < 0.05); post-hoc analysis revealed E-
sired male offspring treated with ethanol performed significantly better on the 5th trial compared 
 45 
to those treated with saline (p < 0.01) (Fig. 12A). For C-sired male offspring, there was a 
significant effect for trial (F(4,56) = 3.48, p < 0.05) but not treatment or interaction of trial with 
treatment (Fig 12B). 
 For E-sired and C-sired female offspring, there were no significant effects of trial, 
treatment, or interaction between trial and treatment (Fig. 12C,D). 
 
Figure 12. Paternal ethanol on accelerating rotarod performance 
Offspring were tested for performance on an accelerating rotarod 35 minutes after i.p. injection of 
1 g/kg ethanol or saline. (A) E-sired male offspring treated with ethanol performed significantly 
better on the 5th trial compared to those treated with saline. There are no significant differences 
associated with ethanol treatment in (B) C-sired male offspring, (C) E-sired female offspring, or 
(D) C-sired female offspring. n = 7-8/group, *p < 0.05. 
2.3.11 Paternal ethanol effects on ethanol clearance rates 
To ensure that differences observed on behavioral assays were not confounded by changes in 
ethanol pharmacokinetics, offspring were tested for the rate at which ethanol was cleared from 
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the venous circulation. There was no significant effect of sire exposure on ethanol clearance in 
males or females (Fig. 13). 
 
Figure 13. Paternal ethanol on ethanol clearance rates 
Ethanol metabolism was measured after i.p. injection of 3.5 g/kg ethanol in saline. There were no 
significant differences in blood ethanol levels 60 minutes and 240 minutes after ethanol treatment 
between E- and C-sired (A) male or (B) female offspring. n = 4-5/group. 
2.3.12 Increased Bdnf expression in VTA of E-sired offspring 
To determine if paternal ethanol exposure leads to changes in gene expression in offspring, Bdnf 
and Dlk1 expression was measure in the VTA and mPFC of offspring. Bdnf is a known regulator 
of ethanol drinking behavior [188-190] whose expression is up-regulated in the mPFC of male 
offspring of cocaine-exposed sires [98]. Dlk1 is expressed from the paternal chromosome and 
regulated by methylation at the IG DMR, which was decreased in motile sperm following 
ethanol exposure in this study; Dlk1 has important roles in neurogenesis [191] and adipogenesis 
[192]. The VTA was chosen because Dlk1 is enriched in this region but has limited expression in 
other regions of the brain [193,194]; Bdnf expression is also enriched at the VTA relative to 
other brain regions [195]. Bdnf exon IXa expression was studied because it is invariably 
expressed with all Bdnf mRNA sequences while Bdnf exon IV is an activity-associated splice 
variant that was increased in male offspring of cocaine-exposed sires [98,196,197]. In the VTA, 
there was increased expression of Bdnf exon IXa but not Bdnf exon IV or Dlk1 in E-sired male 
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offspring (Fig. 14A); there were no differences in gene expression between E and C-sired female 
offspring in the VTA (Fig 14B). Expression of Bdnf exons IV and IXa was also measured in the 
mPFC to study whether changes in expression generalized to another brain structure and to test 
potential similarities between E- and cocaine-sired male offspring. There were no significant 
differences in Bdnf expression between E- and C-sired offspring in the mPFC (Fig. 14C,D). 
 
Figure 14. VTA and mPFC gene expression 
Expression of Bdnf and Dlk1 were measured in the VTA and mPFC of 129xC57 offspring. (A) E-
sired male offspring had significantly increased expression of Bdnf exon IXa but not Dlk1 or Bdnf 
exon IV in the VTA relative to C-sired males. (B) There were no significant differences in Bdnf or 
Dlk1 expression between E- and C-sired females in the VTA. There were no significant 
differences between (C) male and (D) female E- and C-sired offspring in expression of Bdnf exons 
IV and IXa. n = 5-6/group. 
2.3.13 Paternal ethanol regulates DNA methylation at the Bdnf exon IXa promoter 
DNA methylation of the Bdnf exon IXa promoter regulates its expression [198,199]; therefore, it 
is possible that ethanol exposure alters DNA methylation at the Bdnf exon IXa CpG island in 
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sperm and that this epigenetic mark is inherited by male offspring and maintained in the VTA. 
Ethanol exposure significantly decreased DNA methylation of the Bdnf exon IXa promoter in 
motile sperm (Fig. 15A,D) as well as in the VTA of E-sired male offspring (Fig. 15B,E). 
Surprisingly, E-sired female offspring also had decreased DNA methylation at the Bdnf exon IXa 
promoter (Fig. 15C,F).  
 
Figure 15. DNA methylation at the Bdnf exon IXa promoter 
Based on increased expression of Bdnf exon IXa in the VTA of E-sired offspring, DNA 
methylation was measured in sires and offspring VTA. (A,D) Ethanol exposure was associated 
with decreased methylation at the Bdnf exon IXa promoter in motile sperm. Decreased 
methylation was maintained in the VTA of both (B,E) male and (C,F) female offspring. (A-C) 
Each circle represents one of the 17 potentially methylated cytosines in the Bdnf exon IXa 
promoter; filled circles are methylated and unfilled circles are unmethylated. Each block of rows 
represents sequenced colonies from a single independent animal. (D-F) Quantification of bisulfite 
sequencing. n = 4-7/group, *p < 0.05, ***p < 0.001 
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2.4 DISCUSSION 
The results in this aim indicate that ethanol drinking behavior and sensitivity to the behavioral 
effects of ethanol may be epigenetically transmitted through the male lineage. Using isogenic 
mice, these studies demonstrate that exposure of sires to ethanol prior to mating increases 
sensitivity to the anxiolytic and motor effects of ethanol and reduces ethanol preference and 
consumption in male offspring on the two bottle drinking assay.  E-sired male offspring also 
weighed significantly more than C-sired males after weaning, suggesting potential metabolic 
effects of paternal ethanol exposure. An increase in Bdnf expression in the VTA of male but not 
female offspring was also found, which was associated with ethanol-induced changes to DNA 
methylation of the Bdnf promoter in motile sperm as well as the VTA in offspring. While no 
behavioral or gene expression changes were observed in female offspring, they retain 
hypomethylation at the Bdnf promoter in the VTA, though methylation at this region was much 
more variable than compared to males. Notably, no differences were observed in several other 
behavioral assays, suggesting a specific effect of paternal ethanol on ethanol consumption when 
measured using a free choice continuous access drinking paradigm as well as on ethanol-induced 
anxiolysis. 
 One particularly striking feature of the study presented here is how closely the results 
parallel those observed following paternal cocaine [98] and maternal preconception morphine 
[97,200]. Vassoler et al. (2013) demonstrated that consumption of cocaine by sires imparted a 
cocaine resistant phenotype that was restricted to male offspring and females were 
phenotypically normal. The study also found changes in Bdnf expression in the brain in male 
offspring of cocaine-exposed sires. These similarities raise important questions about how drugs 
of abuse with distinct mechanisms of action produce a phenotype of drug resistance in male 
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offspring. One explanation is that both are acting on a common pathway important for encoding 
and maintaining epigenetic marks in germ cells that ultimately control gene expression in brains 
of offspring. The work of Vassoler et al. (2013) implicates cocaine-induced changes in 
posttranslational histone modifications that ultimately influence brain expression of Bdnf in 
male, but not female offspring, as a causative contributor to the observed phenotype. In this 
study, there was increased Bdnf exon IXa expression in only male offspring but DNA 
methylation changes at the Bdnf exon IXa promoter were found in both male and female 
offspring. This result suggests that while ethanol-induced changes to DNA methylation may be 
inherited by both sexes, these changes are not the primary driver of the observed changes in Bdnf 
exon IXa expression. Additional studies are needed to establish a causal role of increased Bdnf 
exon IXa expression in the VTA on ethanol-induced behavioral changes observed in male 
offspring. 
 While this study did not establish causality, Bdnf expression in the VTA regulates drug 
sensitivity, preference, and stress responses (for review, see [201]), indicating it could mediate 
several aspects of our paternal ethanol phenotype. In particular, increased Bdnf expression in the 
striatum, of which a major component is derived from the VTA [202], is associated with 
decreased ethanol consumption [188-190]. Increased Bdnf expression in the VTA also sensitizes 
rodents to the effects of cocaine [203] and amphetamine [204] and decreases morphine 
preference [205]. These studies support increased expression Bdnf in the VTA as contributing to 
decreased ethanol preference and increased sensitivity to drugs of abuse. While studies of VTA-
derived Bdnf on drug-related behaviors support its role in this phenotype, studies of stress 
signaling are more difficult to reconcile. In particular, social defeat stress increases Bdnf 
expression in the VTA and knocking out Bdnf expression in the striatum is associated with stress 
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resilience [206,207]. Moreover, increasing Bdnf expression in the VTA blocks the 
antidepressant-like effects of electroconvulsive therapy [208]. These studies imply that increased 
VTA-derived Bdnf may increase basal stress or depression-like behavior, though this was not 
noted in our EPM or forced swim studies. However, the role of VTA-derived Bdnf in stress and 
depression-like behaviors is not clear cut, as one study noted that treatment with the 
antidepressant fluoxetine increased expression of Bdnf in the VTA [209]. Therefore, studies of 
VTA-derived Bdnf are inconclusive for a general effect on anxiety and stress-related behaviors, 
though effects on specific behaviors have been noted. These studies also highlight the difficulty 
in studying a nonspecific neurotrophic factor, like Bdnf, in behavior and attributing a causal 
effect of increased VTA-dervied Bdnf in our phenotype. 
 Sexually dimorphic effects in offspring have been noted by several studies of 
environmental perturbations in parents [87,89,95,96,98,176]. One explanation for sex-specific 
effects is the influence of the estrous cycle on behavior by daily variation in hormone levels. 
Previous studies have shown that the estrous cycle influences ethanol consumption in female 
rodents [210,211], so that endocrine variation may be masking the effects of paternal ethanol in 
female offspring. Of importance, Bdnf expression is altered by circulating estrogens [212-214], 
so that the estrous cycle may also be masking the effects of hypomethylation at the Bdnf 
promoter on its expression in the VTA. If the estrous cycle was masking the effects of paternal 
ethanol exposure, ovariectomizing females to attenuate the influence of circulating estrogens 
may reveal behavioral and molecular effects of paternal ethanol in female offspring. An 
alternative explanation for lack of an effect in females is that the critical ethanol-induced 
epigenetic modifications in gametes are being passed through the Y chromosome. While the Y 
chromosome contains only ~100 genes across mammals, several of these were found to have 
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critical roles in gene regulation aside from those involved in sex-determination [215]. Therefore, 
we expect future experiments to study expression and epigenetic regulation of these genes. 
 Decreased ethanol preference and consumption for E-sired male offspring is in apparent 
conflict with the familial nature of alcoholism observed in humans. Based on observations in 
human populations that sons of alcoholics have increased risk for alcoholism [216], the initial 
hypothesis of this study was that rodent E-sired offspring would consume more ethanol. While 
the discrepancy between the findings in this study and human studies could simply reflect 
species differences, experimental design issues may also play a role. Whereas humans 
voluntarily consume high quantities of ethanol, this study used forced ethanol exposure via vapor 
inhalation. It is also possible that in genetically heterogenous human populations, genetic 
influences on drinking behavior mask the epigenetic effects of paternal ethanol exposure.  Lastly, 
the effects in this study were observed in a free choice drinking assay and there was no 
difference in ethanol drinking on the scheduled, limited access drinking in the dark assay. 
Considering the range of factors regulating ethanol consumption on these assays, including 
memory, learning, and stress associated with social isolation, it is possible that paternal ethanol 
induces behavioral changes that are specific for particular ethanol drinking paradigms. Other 
behavioral tests of rodent drinking behavior, such as stress-escalated ethanol consumption or 
reward based drinking are necessary to identify specific mechanisms of paternal ethanol of 
ethanol drinking. 
 While the ethanol drinking data are in conflict with human studies, paternal ethanol 
exposure also increased sensitivity to the anxiolytic and motor enhancing effects of ethanol in 
male offspring. In humans, increased sensitivity to the subjective effects of ethanol is associated 
with decreased risk of developing alcoholism [216]. Notably, in this study, increased sensitivity 
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to ethanol in E-sired male offspring was associated with decreased ethanol consumption. 
Heritability of ethanol sensitivity on motor tests has also been noted in humans. Of note, static 
ataxia (body sway) after ethanol consumption shows heritability and is associated with a sexually 
dimorphic pattern of inheritance [217]. Compared to C-sired male offspring, E-sired males were 
more sensitive to low dose ethanol enhancement of motor coordination on the accelerating 
rotarod assay and to locomotor stimulation (and anxiolysis) on the elevated plus maze but not on 
the open field assay. The discrepancy between the elevated plus maze and open field locomotor 
results was likely due to the ethanol dose and timing, since several studies have reported 1 g/kg 
ethanol did not induce changes in locomotion on the open field assay [218-220]. It is also notable 
that E-sired male offspring demonstrated subtle changes on the accelerating rotarod assay, with 
only the 5th trial reaching statistical significance compared to C-sired male offspring. This 
finding is more suggestive of an effect on motor learning than locomotor enhancement. These 
issues raise the possibility that paternal ethanol exposure affects discrete pathways to alter 
sensitivity to ethanol. There was also no effect of paternal ethanol exposure on ethanol 
metabolism in offspring, which is consistent with human studies of children of alcoholics [221]. 
These findings suggest that behavioral differences in E-sired offspring are being driven by 
neurobiological changes that alter sensitivity to ethanol to decrease drinking. 
 Ethanol exposure induced hypomethylation at two loci studied in motile sperm and 
hypomethylation at one of these, the Bdnf exon IXa promoter, was maintained in the VTA of E-
sired offspring. This finding is consistent with studies that show both maternal and paternal 
preconception ethanol exposure alter DNA methylation at imprinted loci in offspring [86,156]. 
While ethanol’s effects on DNA methylation in offspring are striking, ethanol is known to alter 
several epigenetic marks across tissue types and could act as a broader epimutagen in sperm. For 
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example, ethanol alters histone modifications in the amygdala, which contribute to its acute 
anxiolytic effects and withdrawal-induced anxiety [60,137]. miRNA regulation by ethanol has 
been shown to underlie changes in expression of BK channel splice variants [222]. Therefore, it 
is conceivable that ethanol induces multiple heritable epigenetic modifications in germ cells and 
these marks are maintained in the brain of offspring sired by alcohol exposed fathers. 
 This idea is especially intriguing considering epigenetic reprogramming during 
spermatogenesis is highly plastic. These changes include chromatin compaction by replacement 
of most histones with protamines, de novo DNA methylation and maintenance, and silencing of 
retrotransposable elements through numerous small regulatory RNAs [223]. As discussed 
previously, ethanol acts as an epimutagen in other tissues and may be affecting multiple 
epigenetic processes during spermatogenesis. A rodent study demonstrated chronic ethanol 
exposure decreases cytosine methyltransferase levels in the testes [155], which is consistent with 
decreased DNA methylation at the IG DMR and Bdnf exon IXa promoter in this study. A recent 
human study also demonstrated that ethanol consumption was correlated with decreased 
methylation of imprinted genes that are normally hypermethylated in human sperm [152]. 
Ethanol’s effects on DNA methylation in gametes are further supported by the observation that 
chronic ethanol alters methionine metabolism [224], which is critically involved in the function 
of cytosine methyltransferases [225]. Additional studies should expand on DNA methylation as 
well as begin to study ethanol-induced changes to retained histones and noncoding RNAs. 
 In conclusion, upon paternal ethanol exposure, ethanol likely functions as an epimutagen 
imparting long lasting effects on germ cells that ultimately impact the next generation. Prior 
rodent studies demonstrated an impact of paternal ethanol exposure on brain development and 
numerous basal behaviors. The results presented here demonstrate an effect on behavioral 
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sensitivity to ethanol, ethanol drinking behavior, and gene expression that is restricted to male 
offspring. If these rodent studies apply to humans drinking alcohol, the results have far reaching 
implications considering the large percentage of the human population that consume alcohol 
prior to procreation.   
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3.0  EPIGENETIC MECHANISMS OF ETHANOL IN THE CORTEX 
Adapted from: Finegersh A, Homanics GE (2014) Acute Ethanol Alters Multiple Histone 
Modifications at Model Gene Promoters in Cerebral Cortex. Alcohol Clin Exp Res 38: 1865-73. 
[226] 
3.1 INTRODUCTION 
AUD is associated with widespread changes in gene expression across multiple brain structures 
[118,119,122,123]. These changes underlie neuronal and glial adaptations to the environmental 
stress of repeated ethanol exposure and may contribute to the reinforcing effects of ethanol that 
incentivize further consumption [125]. In rodents, a single, binge-like exposure to ethanol is also 
associated with up- and down-regulation of genes in the cortex, nucleus accumbens, and ventral 
tegmental area [68,69,128]. Despite the importance of differential gene expression for ethanol 
action, mechanisms of gene regulation by ethanol are poorly understood. 
 Gene expression is regulated by epigenetic mechanisms, which include covalent 
modifications to histones and DNA [227]. These modifications alter affinity of histones for DNA 
to inhibit or promote transcription factor binding. In particular, modifications to histone N-
terminal tails, including acetylation and methylation of lysine residues, are catalyzed by a large 
group of histone modifying enzymes and represent a rapid, reversible method of chromatin 
 57 
alteration [32]. These enzymes can be induced by drugs of abuse, like ethanol, to establish 
chromatin alterations that promote drug-seeking behavior and addiction [28]. 
 Recent evidence highlights the role of ethanol in inducing epigenetic disruptions and 
modulating histone modifying enzyme expression in the brain. Studies of patients with AUD 
have identified altered distribution of histone trimethylation in the hippocampus and cortex, 
which correspond to gene expression changes in these regions [122,123]. In rodents, acute 
ethanol is associated with increased histone acetylation in the central nucleus of the amygdala 
[60], altered histone modifications at the prodynorphin and pronociceptin promoters in the 
amygdala [135], and altered expression of histone modifying enzymes in the striatum and 
prefrontal cortex [141]; moreover, pre-treatment with the HDAC inhibitor sodium butyrate 
blocks ethanol-induced behavioral sensitization, indicating histone deacetylation plays a critical 
role in the neuroadaptive response to ethanol administration [142]. A recent study pointed to 
HDAC2 expression in the amygdala as a critical regulator of ethanol preference and anxiolytic 
response to acute ethanol, identifying a specific histone modifying enzyme in mediating ethanol 
action [137]. 
 While epigenetic effectors of ethanol are now seen as potential targets for the treatment 
of AUD, several important questions remain to be resolved. Of note, studies of acute ethanol 
have focused on epigenetic modifications at up-regulated genes; however, gene expression 
studies indicate both up- and down-regulation of genes in response to acute ethanol [68,69,128]. 
Moreover, while acute ethanol-induced histone modifications have been characterized in the 
amygdala using chromatin immunoprecipitation (ChIP) [135,137], no studies have examined 
broader effects of acute ethanol in the cerebral cortex (CCx). The CCx is a critical site of 
ethanol’s effect on GABAA receptor potentiation [228,229], motor control [230], and neuronal 
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toxicity [231,232]. Due to its sensitivity to ethanol and diversity of cell types, the CCx may be 
especially important for identifying general epigenetic effects of ethanol in the brain that will be 
useful for screening potential drug targets. Therefore, this study examines the effects of acute 
ethanol on multiple histone modifications at promoters of both up- and down-regulated genes in 
the CCx. 
 In this section, a single binge-like dose of ethanol (3 g/kg i.p.) known to produce 
sustained alterations in gene expression in mouse CCx [233] was used to study how acute 
ethanol alters histone acetylation and methylation at the promoters of three model up- and down-
regulated genes, global levels of those histone modifications, and the expression of histone 
modifying enzymes in CCx. 
3.2 MATERIALS AND METHODS 
3.2.1 Animals and Treatments 
 All experiments were approved by the Institutional Animal Care and Use Committee of 
the University of Pittsburgh and conducted in accordance with the National Institutes of Health 
Guidelines for the Care and Use of Laboratory Animals. All experiments were performed using 
8-week-old, ethanol-naïve, specific pathogen free male C57BL/6J mice from the Jackson 
Laboratory (20 – 25 g). Mice were habituated to the University of Pittsburgh animal facility for 1 
week prior to initiation of experiments. Mice were housed under 12 hour light/dark cycles and 
had ad libitum access to food and water. 
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 All treatments were administered during the light cycle between 08:00 and 10:00. Mice 
were given i.p. injections containing 0.02 ml/g of either 15% ethanol solution in saline (3 g/kg 
ethanol) or saline alone. After injections, mice were individually housed for 6 hours with ad 
libitum access to food and water. 
 At 6 hours post-injection, mice were rapidly sacrificed by carbon dioxide asphyxiation 
and decapitated. The brain was immediately removed and placed on a petri dish on ice. The 
cerebellum was removed and cerebral hemispheres separated at midline. The olfactory bulbs 
were removed and the telencephalon (CCx) was carefully dissected from the diencephalon and 
midbrain. The hippocampus (HC) was dissected and removed from the CCx. The remaining left 
and right CCx and HC were flash frozen separately in liquid nitrogen. All experiments were 
performed using either the left or right CCx or HC.  
3.2.2 Reverse Transcription Quantitative PCR (RT-aPCR) 
 Total RNA was isolated using TRIzol according to the manufacturer’s protocol 
(Invitrogen), purified with DNase digestion (Qiagen), and 1 μg of RNA was synthesized into 
cDNA using reverse transcriptase (RT) (Bio-Rad). A no-RT reaction was used as a negative 
control. Reactions were carried out in duplicate for each gene. SYBR green fluorescent master 
mix (Bio-Rad) was added to each well and visualized using a Bio-Rad iCycler. All primers were 
optimized for 90% to 110% efficiency at the following conditions: 10 min at 95˚C (initial 
denaturation) followed by 40 cycles of 30 s at 95˚C (denaturation), 1 min at 60˚C (annealing), 
and 30 s at 72˚C (extension). Primer sequences for β-actin, Gad1, Mt1, Mt2, Egr1, Hdac2, 
Hdac11, Csrp2bp, and Kat2b are shown in Table 4. Threshold cycle (Ct) values were calculated 
for each well and duplicate values averaged. The difference between specific genes and β-actin 
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(ΔCt) was calculated for each animal and normalized to the average of saline-treated animals 
(ΔΔCt). Fold change over saline controls was calculated for each animal using the following 
formula: 2-ΔΔCt. 
3.2.3 Chromatin Immunoprecipitation (ChIP) 
Chromatin was isolated from the CCx using a standard protocol and reagents (Millipore EZ-
Magna ChIP). Briefly, the CCx was minced on a petri dish over ice using a razor blade. DNA 
was cross-linked to histones by incubating minced tissue in 1 ml of 1% formaldehyde in 
phosphate buffered saline (PBS) at 37˚ C for 10 minutes. The formaldehyde reaction was 
quenched using glycine and the tissue was washed 3 times in PBS with protease inhibitor 
cocktail (Roche #04693116001). Cell lysis buffer (Millipore) with protease inhibitor was added 
and nuclei pelleted. The nuclear pellet was incubated on ice in 500 μL nuclear lysis buffer 
(Millipore) with protease inhibitor to generate chromatin. Chromatin was sheered in an ice water 
bath using 4 bursts of 15 s at 35% output and 80% duty cycle on a Branson Sonifier S-250A. An 
aliquot of sheered, cross-linked DNA was removed and run on a 1.5% agarose gel to ensure the 
majority of DNA was between 200 and 600 bp. Chromatin was aliquotted and stored in dilution 
buffer (Millipore) with protease inhibitor at -80˚C until immunoprecipitation experiments. 
 For immunoprecipitation, chromatin in dilution buffer was thawed on ice and 2% of the 
volume was removed and saved as the input. The remaining chromatin was incubated at 4˚C 
overnight with antibody and Protein A/G magnetic beads (Millipore) with end-over-end rotation. 
The following antibodies were used for immunoprecipitation reactions: histone subunit H3 
acetylated at lysines 9 and 14 (H3K9,14ac) (Millipore, #06-559b), histone subunit H3 tri-
methylated at lysine 4 (H3K4me3) (Epigentek, #A-4033), and histone subunit H3 tri-methylated 
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at lysine 27 (H3K27me3) (Millipore, #17-622). IgG (Millipore, #PP64B) was used as a negative 
control. Antibodies were screened by assessing enrichment of the constitutively active gene, β-
actin, over the neuronally repressed gene, ε-globin; there was no difference in enrichment 
between ethanol and saline treated animals (Fig. S1) [234]. Antibodies were also validated by 
assessing binding to peptide arrays containing 46 histone modifications to the H3 N-terminal tail 
(Millipore #16-667); H3K27me3 and H3K4me3 antibodies bound to their stated histone 
modifications while the H3K9,14ac antibody bound H3K9ac but not H3K14ac (data not shown). 
After incubation, magnetic beads containing antibody-chromatin complexes were immobilized 
on a magnetic rack and washed once with low salt, high salt, and LiCl immune complex wash 
buffers and TE. Elution buffer (Millipore) with proteinase K was added and the complexes were 
incubated at 65˚C for 2 hours to elute enriched DNA. Immunoprecipitated and input DNA was 
purified using a ChIP DNA kit (Zymo Research) and eluted in 100 μL elution buffer. 
 For qPCR, 5 μL of immunoprecipitated or input DNA was used in each well and carried 
out in duplicate or triplicate for each primer pair. qPCR conditions were the same as reported in 
the RT-qPCR section and all ChIP-qPCR primers were optimized to perform at 90% to 110% 
efficiency. Primer sequences for promoter regions of β-actin, ε-globin, Gad1, Mt1, Mt2, Egr-1, 
Hdac2, and Hdac11 are listed in Table 4. Ct values were normalized to input DNA and a 
negative control region not enriched for the histone modification [235-237]. For H3K9,14ac and 
H3K4me3, ε-globin served as the negative control region; for H3K27me3, β-actin served as the 
negative control region. Data are presented as fold enrichment over saline controls. 
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 Table 4. Primer sequences for qPCR experiments 
*TSS, Transcriptional Start Site 
3.2.4 RT-qPCR array 
A RT-qPCR array containing primers for 84 chromatin modifying enzymes was used to screen 
ethanol-induced gene expression changes according to the manufacturer’s protocol (SA 
Biosciences, #PAMM-085; full gene list shown in Supplementary Table 2). RNA was extracted 
and purified according to the RT-qPCR section, converted to cDNA, and 8.5 ng of cDNA used 
per well according to the manufacturer’s protocol. A total of 6 PCR arrays were used (3 saline-
treated and 3 ethanol-treated animals). qPCR conditions were 10 min at 95˚C (initial 
denaturation) followed by 40 cycles of 15 s at 95˚C (denaturation) and 1 min at 60˚C (annealing 
and extension). Ct values from each PCR array were normalized to the median Ct value of that 
array (median normalization). Median normalized Ct values were further normalized to the 
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average of saline controls (ΔΔCt) and fold change values calculated using the following formula: 
2-ΔΔCt. 
 Genes whose expression was changed >100% after ethanol treatment or had a p-value 
<0.1 and change in expression >25% were chose for validation by RT-qPCR using an additional 
6 mice per group. 
3.2.5 Western Blot 
 Histone lysates were extracted using the Qiagen Qproteome kit according to the 
manufacturer’s protocol and quantified using a Bradford assay. Twenty ug of histone lysate was 
loaded onto 4%-20% Novex Tris-glycine gel (Invitrogen) and transferred to a nitrocellulose 
membrane. Membranes were blocked in Odyssey buffer (LiCor Biosciences) and incubated 
overnight with primary antibodies. The following antibodies were used for Western blots 
according to the manufacturer’s protocol: histone subunit H3 (Santa Cruz Biotechnologies, #sc-
8654), H3K9ac (Cell Signal Technologies, #9671s), H3K14ac (Millipore, #07-353), H3K4me3 
(Epigentek, #A-4033), and H3K27me3 (Millipore, #17-622). After overnight incubation, 
membranes were incubated with secondary fluorescent antibodies according to the 
manufacturer’s protocol (LiCor Biosciences) and visualized using the Odyssey Infrared Imaging 
System (Licor Biosciences). The total intensity of each band was divided by the total intensity of 
histone subunit H3 and presented as a percent change relative to the average of saline controls. 
For CCx, A total of 6 animals per group were assessed on 2 separate membranes. For HC, a total 
of 3 animals per grouped were assessed on 2 separate membranes. Membranes were stripped 
four times using stripping buffer (LiCor Biosciences) between incubations with primary 
antibody. 
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3.2.6 Statistical Analysis 
 For RT-qPCR, ChIP-qPCR, and Western blot quantification, a two-tailed, unpaired t-test 
was used to compare the ethanol and saline treated groups.  Statistical significance was defined 
by a p-value < 0.05. All data are presented as mean +/- SEM. 
3.3 RESULTS 
3.3.1 Ethanol-induced histone modifications at down-regulated genes 
Genes down-regulated by acute ethanol exposure were identified using previously published 
microarray data [68,69,128] and the RT-qPCR array used in this study. Six hours after injection 
of 3 g/kg ethanol or saline there was significantly decreased expression of glutamic acid 
decarboxylase 1 (Gad1) (p < 0.05), Hdac2 (p < 0.05), and Hdac11 (p < 0.05) in the CCx of 
ethanol-treated compared to saline-treated mice (Fig. 16A).  
ChIP assays revealed changes to histone modifications at the Gad1 and Hdac2 promoters 
six hours after injection of 3 g/kg ethanol (Fig. 16B-D). There was a significant decrease in the 
association of the Gad1 and Hdac2 promoters with H3K9,14ac in the CCx of ethanol-treated 
compared to saline-treated mice (p < 0.05). There was also a paradoxical decrease in the 
association of the Gad1 promoter with H3K27me3 in the CCx of ethanol-treated compared to 
saline-treated mice (p < 0.05). We did not identify ethanol-induced changes in the association of 
either promoter with H3K4me3 or the association of the Hdac11 promoter with the studied 
histone modifications. 
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Figure 16. Ethanol-induced histone modifications at down-regulated genes 
Ethanol-induced histone modifications were studied at the model down-regulated genes, Gad1, 
Hdac2, and Hdac11. (A) Acute ethanol significantly decreased expression of Gad1, Hdac2, and 
Hdac11 ChIP-qPCR revealed that (B) the Gad1 and Hdac2 promoters had a significantly 
decreased association with H3K9,14ac, (C) no change in association of either gene with 
H3K4me3, and (D) that the Gad1 promoter has a significantly decreased association with 
H3K27me3. n = 6/group, *p < 0.05. 
3.3.2 Ethanol-induced histone modifications at up-regulated genes 
Metallothioneins are components of the cellular response to oxidative stress whose expression is 
robustly increased by ethanol exposure [69,128]. Early growth response 1 (Egr1) is an 
immediate early gene whose expression also increases following ethanol exposure [238]. Six 
hours after injection of 3 g/kg ethanol or saline there was significantly increased expression of 
metallothioneins 1 (Mt1) (p < 0.05), 2 (Mt2) (p < 0.01), and Egr1 (p < 0.05) in the CCx of 
ethanol-treated compared to saline-treated mice (Fig. 17A). 
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 ChIP assays revealed changes to histone modifications at the Mt1 and Mt2 but not Egr1 
promoters six hours after injection of 3 g/kg ethanol (Fig. 17B-D). There was a significant 
decrease in the association of the Mt1 promoter with H3K27me3 but not H3K9,14ac or 
H3K4me3 in the CCx of ethanol-treated compared to saline-treated mice (p < 0.05). There was a 
significant increase in the association of the Mt2 promoter with H3K4me3 but not H3K9,14ac or 
H3K27me3 in the CCx of ethanol-treated compared to saline-treated mice (p < 0.05). 
Surprisingly, there were no ethanol-induced changes in the association of model up-regulated 
gene promoters with H3K9,14ac.  
 
Figure 17. Ethanol-induced histone modifications at up-regulated genes 
Ethanol-induced histone modifications were studied at the model up-regulated genes, MT1, MT2, 
and Egr-1 (A) Ethanol exposure significantly increased expression of Mt1, Mt2, and Egr1. ChIP-
qPCR studies revealed (B) no changes in association of up-regulated genes with H3K9,14ac, (C) 
increased association of the Mt2 promoter with H3K4me3, and (D) decreased association of the 
Mt1 promoter with H3K27me3. n = 6/group, *p < 0.05, **p < 0.01. 
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3.3.3 Acute ethanol alters histone modifications in CCx 
To study whether acute ethanol alters global levels of the histone modifications assessed 
using ChIP, Western blot was performed on histone lysates generated from the CCx. There was a 
significant increase in global levels of H3K4me3 but no significant change in H3K9ac, 
H3K14ac, or H3K27me3 levels in the CCx six hours after injection of 3 g/kg ethanol compared 
to saline (Fig. 18). 
 
Figure 18. Histone modifications in CCx after acute ethanol 
Western blot was used to assess global levels of histone modifications; data were quantified from 
6 independent samples run across 2 separate gels. (A) Representative Western blot of ethanol and 
saline-treated animal histone lysates. (B) Quantification of protein levels normalized to total H3 
presented as percent change over saline controls. n = 6/group, *p < 0.05. 
3.3.4 Acute ethanol alters histone modifying enzyme expression 
To identify mechanisms of ethanol-induced changes to histone modifications, we used a RT-
qPCR array containing primers for all known HDACs as well as histone acetyltransferases 
(HAT), methyltransferases, and other enzymes involved in covalent modification of chromatin 
(full results in Appendix B). The RT-qPCR array demonstrated low variability between ethanol 
and saline-treated animals with few changes in the expression of chromatin modifying enzymes 
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associated with ethanol treatment in the CCx (Fig. 19A). This low power, screening assay 
revealed that Csrp2bp, Hdac2, Hdac11, and Kat2b met criteria for validation with an additional 
6 animals per group. 
 PCR validation revealed six hours after injection of 3 g/kg ethanol or saline there was 
significantly decreased expression of Hdac2, Hdac11, and Csrp2bp and a near-significant trend 
for increased expression of Kat2b in the CCx of ethanol-treated compared to saline-treated mice 
(Fig. 19B).  
 
Figure 19. Acute ethanol alters chromatin modifying enzyme expression in CCx 
(A) Volcano plot showing the p-value (y-axis) and fold regulation [log2(fold change)] (x-axis) of 
all 84 chromatin modifying enzymes with positions of Csrp2bp, Hdac2, Hdac11, and Kat2b 
indicated; vertical dashed lines indicate 25% change in expression and the horizontal dashed line 
indicates a p-value of 0.1 for ethanol-treated animals compared to saline controls. (B) PCR 
validation of Csrp2bp, Hdac2, Hdac11, and Kat2b. n = 9/group, *p < 0.05, **p < 0.01, #p = 
0.056. Note: Hdac2 and Hdac11 expression data is identical to that presented in Figure 16. 
3.3.5 Ethanol-induced epigenetic modifications in the hippocampus 
To study whether epigenetic modifications generalized to another brain structure, global levels of 
histone modifications and expression of chromatin modifying enzymes that were altered in CCx 
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were measured in HC from the same mice. Western blot results revealed a significant increase in 
global levels of H3K9ac and H3K14ac as well as a nonsignificant trend for an increase in 
H3K4me3 with no change in levels of H3K27me3 six hours after injection of 3 g/kg ethanol 
compared to saline (Fig. 20A,B). There were no significant differences in expression of Hdac2, 
Hdac11, Csrp2bp, or Kat2b in ethanol compared to saline-treated mice in the HC (Fig. 20C). 
 
Figure 20. Ethanol-induced histone modifications in the hippocampus 
Western blot was used to assess global levels of histone modifications; data were quantified from 
3 independent samples per ethanol and saline groups run across 2 separate gels. RT-qPCR was 
used to study expression of chromatin modifying enzymes (n = 9/group) (A) Representative 
Western blot of ethanol and saline-treated animal histone lysates. (B) Quantification of protein 
levels normalized to total H3 presented as percent change over saline controls. (C) Csrp2bp, 
Hdac2, Hdac11, and Kat2b expression was not altered in the HC in ethanol-treated compared to 
saline-treated mice.  *p < 0.05, #p = 0.0873. 
3.4 DISCUSSION 
These data demonstrate novel epigenetic mechanisms of ethanol-regulated gene promoters, 
which indicate a diverse pattern of histone modifications induced by acute ethanol. Of note, this 
is the first study to identify histone deacetylation at gene promoters in the brain following acute 
ethanol exposure. Altered expression of four histone modifying enzymes, Hdac2, Hdac11, 
Kat2b, and Csrp2bp, was also discovered as well as an increase in H3K4me3 throughout the 
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CCx and at the Mt2 gene promoter. Finally, this study revealed increased histone acetylation in 
the HC with no change in expression of chromatin modifying enzymes that were altered in CCx, 
suggesting differences in ethanol-induced epigenetic changes between these structures. 
 Histone deacetylation at our model down-regulated gene promoters indicates that acute 
ethanol leads to recruitment of HDACs to a subset of gene promoters. This finding is surprising 
considering several studies show acute ethanol exposure is associated with decreased HDAC 
activity and expression [60,138,139,141]. However, there is also compelling evidence for histone 
deacetylation after acute ethanol exposure. In particular, down-regulation of genes by acute 
ethanol in the brain has been reported by several micro-array studies [68,69,128] and implies a 
role for HDACs in mediating the acute effects of ethanol. A recent study also revealed decreased 
acetylation of histone subunit H4 in the nucleus accumbens 4 hours after the onset of binge 
drinking [239]. These studies highlight the diversity of epigenetic mechanisms induced by acute 
ethanol and importance of characterizing ethanol-induced histone modifications at specific gene 
promoters. This is especially important since several studies have proposed a role for HDAC 
inhibitors for modulating ethanol consumption [60,137,139,239]. Future studies should expand 
on the current findings by studying both temporal and gene-specific effects of ethanol on histone 
acetylation. 
 Ethanol-induced epigenetic changes at two model up-regulated gene promoters were 
identified by this study. Notably, H3K4me3 was increased at the Mt2 promoter and H3K27me3 
was decreased at the Mt1 promoter. Ethanol-induced changes to these histone modifications have 
been reported previously [135]. However, surprisingly, there was no increase in H3K9,14ac at 
any of the model up-regulated gene promoters in this study. This finding was surprising, since 
several studies have found that acute ethanol increases histone acetylation in the brain 
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[60,137,139]. One explanation for no change in histone acetylation at these gene promoters is 
that they have returned to a baseline state. Importantly, Mt1, Mt2, and Egr1 expression has been 
shown to be elevated four hours following ethanol exposure [128], so that it is possible that the 
promoters are no longer active at the 6 hour time point studied in this paper. This finding 
highlights the dynamic nature of epigenetic gene regulation induced by ethanol and future 
studies should identify gene promoter states at multiple time points. 
 Increased levels of H3K4me3 have been reported in the cortex of patients with 
alcoholism [122] and the results in this study indicate that this occurs after a single ethanol 
exposure. Importantly, H3K4me3 exclusively marks active and poised promoters near 
transcriptional start sites [34,240], so that a global increase in this histone modification likely 
reflects ethanol-induced chromatin remodeling to promote gene expression. While the RT-qPCR 
array did not detect a change in expression of lysine methyltransferases or demethylases, these 
enzymes are regulated by post-translational modifications that could account for increased 
histone tri-methylation after ethanol exposure [34]. Further studies are needed to identify how 
ethanol induces tri-methylation of lysine 4 on histone subunit H3 without altering expression of 
histone methyltransferases. 
  The analysis of chromatin modifying enzyme expression following acute ethanol 
exposure identified two HDACs and two HATs whose expression is altered in the CCx. Notably, 
decreased expression of Hdac2 and Hdac11 after acute ethanol exposure has been reported in the 
striatum [141], indicating down-regulation of these genes is a fundamental neurobiological 
mechanism of ethanol. Hdac2 expression has been implicated in conferring preference for 
ethanol [137] and down-regulation promotes memory formation [241], so that decreased 
expression may be important for promoting further ethanol consumption. Differential expression 
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of Hdac11 was found to regulate ethanol drinking behavior [242], though specific mechanisms 
of Hdac11 in the brain have not been identified. Based on these findings and similar changes in 
expression in the striatum [141], studying ethanol-induced regulation of Hdac2 and Hdac11 will 
likely help elucidate mechanisms of ethanol-induced gene expression. 
 Changes in expression of two HATs in the CCx after ethanol exposure likely reflect 
competition between HAT complexes. Csrp2bp is a component of the ATAC complex, which 
acts as a HAT that regulates cell cycle progression [243]. Kat2b is a component of a HAT 
complex with CREB binding protein, which is critical for memory formation [244]. 
Interestingly, the ATAC complex was found to be mutually exclusive with a HAT complex 
containing Kat2b [245], so that inverse expression of Kat2b and Csrp2bp may reflect ethanol-
induced mechanisms that activate one HAT complex and repress the other. This idea is 
supported by studies indicating the importance of CREB for mediating ethanol action [246] and 
also suggest repression of the ATAC complex as a mechanism of ethanol. Studying how 
modulating the ATAC and CREB complexes affects ethanol consumption would further support 
the idea that ethanol induces reciprocal activation of these HAT complexes. 
 One important limitation of this study is that it analyzes one relatively short (80 - 120 bp) 
region of the gene promoter near the transcriptional start site (TSS) (Table 4). Importantly, the 
histone modifications studied are associated with differential states of the TSS, including 
H3K27me3 at poised and repressed genes, H3K4 methylation at poised and active genes, and 
H3K9ac at active genes [247]. Altering levels of these modifications at the TSS likely involves 
moving between repressed, poised, or active states and changes in gene expression. However, 
several of the genes studied did not have changes to these modifications at the TSS. As discussed 
above, this may reflect the dynamic nature of these modifications and negative feedback to a 
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baseline state following an ethanol-induced change in gene expression. Alternatively, it is 
possible that changes to histone modifications occur far from the TSS at regulatory regions that 
govern transcription factor binding to the gene promoter. These regions primarily function as 
enhancers, which recruit transcription factors to potentiate gene expression [248]. For example, 
metallothioneins have glucocorticoid, metal, and antioxidant response elements in their gene 
promoters, which can be bound by transcription factors to increase expression [249]. The Mt2 
gene also contains a consensus Egr1 binding sequence (5’-GCGGGGGCG-3’) near the TSS and 
the primers used for ChIP in this study spanned this region, though only changes in H3K4me3 
levels were noted (Fig. 17). Given the potential for transcription factor interactions with histone 
modifying enzymes at enhancers, tiling primer sequences across larger spans of differentially 
expressed gene promoters may have identified changes in histone modifications at regulatory 
elements further from the TSS. Additionally, genome-wide studies of histone interactions using 
ChIP-chip or ChIP-seq may identify changes to histone modifications at cis-acting regulatory 
elements that may be up to 1 Mb away from the TSS. 
 This study raises important points about studying epigenetic mechanisms of ethanol. It 
identified general mechanisms of acute ethanol on histone modifications and chromatin 
modifying enzyme expression as well as specific mechanisms at gene promoters using ChIP in 
the CCx. The findings indicate that changes seen on a global level do not generalize to all or 
even most gene promoters across the CCx. This is likely due to the dynamic nature of histone 
modifications and differences among neuronal subpopulations that influence ethanol-induced 
epigenetic changes, which limit the study’s ability to identify specific effects at gene promoters. 
It is also interesting that chromatin modifying enzymes whose expression was altered in CCx 
were not altered in HC, suggesting changes in CCx expression may be driven by a specific 
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region or population of cells. Recent work indicates that ethanol-induced epigenetic changes are 
different even between different subregions of the same brain structure [60,137,139,141], so that 
it is not unexpected ethanol-induced gene expression changes differ between CCx and HC. These 
issues may have precluded identification of a discrete pattern of ethanol-induced histone 
modifications shared by any of the six studied promoters. Future studies should examine 
additional time points of ethanol exposure as well as study neuronal subtypes by utilizing laser 
capture microdissection or fluorescence activated cell sorting. Lastly, since the current study 
utilized C57BL/6J male mice, it is of interest to determine if the results observed generalize to 
females and to mice of other genetic backgrounds. 
 In conclusion, this study introduces new epigenetic mechanisms of ethanol, including 
histone deacetylation at down-regulated gene promoters, increased global H3K4me3, and altered 
expression of histone modifying enzymes in the CCx following acute ethanol exposure. 
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4.0  NEURONAL SUBTYPE SPECIFIC ANALYSIS OF ETHANOL-INDUCED 
EPIGENETIC MODIFICATIONS 
4.1 INTRODUCTION 
In Section 3 of this dissertation, epigenetic effects of ethanol were revealed in CCx and HC. 
Those experiments relied on identifying model genes altered by acute ethanol and studying 
histone modifications at the promoters of those genes. While this study detected changes in 
histone modifications at several gene promoters, it may have been limited from detecting more 
by technical issues inherent to studying histone modifications in a complex tissue like the brain. 
 These issues relate to the ability to detect changes in RNA transcript levels vs. the ability 
to detect changes in histone modifications at gene promoters using ChIP. For instance, while a 
cell may produce hundreds of RNA molecules of the same transcript, it only contains two loci 
for those RNA sequences in the genome (excluding the potential contribution of copy number 
variation). Therefore, it may be difficult to detect changes in histone modifications at a specific 
gene promoter using chromatin made from millions of cells if only a few hundred cells are 
contributing to a detectable increase in RNA transcript number. This issue may be especially 
relevant in the brain, which is composed of hundreds of neuronal subtypes, glia, and other cell 
types with distinct transcriptional profiles [250]. Additionally, substantial loss of chromatin 
occurs during formaldehyde cross-linking, multiple cell lysis steps, and sonication that are 
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components of nearly all standard ChIP protocols, so that most protocols recommend using tens 
of millions of cells as input [251,252]. Some of these limitations are overcome using cell culture 
systems where histone modifications within a distinct cell type can be studied; however, this 
lacks complexity relative to whole animal models. 
 With new evidence emerging for cell-type specific transcriptional regulation by drugs of 
abuse [55,61,253], studying epigenetic modifications specific to these cell types would greatly 
improve understanding of drug-induced gene regulation. Additionally, studying a homogenous 
cell population with similar transcriptional profiles will likely increase the sensitivity of ChIP to 
detect changes in histone modifications at gene promoters. Several recent advances in methods to 
isolate neuronal subtypes in the brain have made this possible. In particular, laser capture 
microdissection allows for visualization and selection of cell types in brain tissue [254]. 
Fluorescence activated cell sorting (FACS) is now being applied to sorting cell types in the brain 
based on antibody-mediated or endogenous cell fluorescence. For this study, FACS was chosen 
to isolate a neuronal subtype because it allows for quantifiable sorting of live cells and collection 
of thousands of cells in a short time (~1 hour) for downstream analysis. 
Several recent studies have utilized FACS to identify transcriptional profiles of neuronal 
subtypes after drug administration. Many of these studies were made possible by the Gene 
Expression Nervous System Atlas project, which developed transgenic mice with promoter-
specific fluorescent proteins integrated into the genome using bacterial artificial chromosomes 
(BAC) [255]. Identification of neuronal subtypes using BAC transgenic strains is highly specific 
and these animals have been used in anatomical, electrophysiological, and optogenetic studies 
[255-257]. An early paper utilized BAC transgenic mice and FACS to identify transcriptional 
differences between dopamine D1 receptor (D1R) and dopamine D2 receptor (D2R) medium 
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spiny neurons (MSN) in the striatum [258]. Eric Nestler’s group expanded on this study by 
showing cocaine has differential effects on gene expression in D1R and D2R MSNs [259]; 
moreover, epigenetic mechanisms intrinsic to these cells were found to underlie how they 
respond to cocaine [61]. A recent study utilized BAC transgenic strains along with antibody-
mediated tagging of histone modifications to examine how cocaine alters histone modifications 
in D1R and D2R MSNs [260]. Other groups have used antibody-mediated FACS to study gene 
regulation induced by cocaine [261], opioids [262,263], and methamphetamine [264] in cellular 
subtypes. However, while antibody-based approaches allow for selection of a wider array of cell 
types compared to BAC transgenic strains, they also require fixing cells and have issues with off-
target binding of antibodies that may reduce their specificity. Though several groups have now 
used FACS to show neuronal subtype specific gene regulation by drugs of abuse, I did not 
identify any studies that utilized this approach for ethanol exposure. Additionally, while one 
group reported using antibody-mediated FACS to study chromatin in neurons [265], I did not 
identify reports of a ChIP protocol for use in neuronal subtype-specific BAC transgenic strains. 
This study utilized a commercially available BAC transgenic strain where the D1R 
promoter drives expression of tdTomato, a variant of the red fluorescent protein. This strain has 
been well-characterized with tdTomato expression restricted to D1R MSNs and no apparent 
behavioral differences relative to wild type mice [266]. D1R MSNs in the NAc are critical 
components of reward signaling, integrating dopaminergic inputs from the VTA and 
glutamatergic inputs from limbic structures to guide goal-directed behaviors [267]. Importantly, 
ethanol consumption potentiates the NAc in both rodents [268] and humans [269], suggesting 
this is a critical feature in the development of AUD. In particular, chronic ethanol exposure was 
found to hyperactivate the VTA and increase PKA activity, a downstream effector of the D1R, in 
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the NAc [270]. Studies have now specifically implicated the D1R in the NAc in mediating 
several effects of ethanol. A study utilizing D1R and D2R BAC transgenic strains found 
increased ΔFosB staining in D1R but not D2R neurons following ethanol exposure [55]. 
Knocking down or pharmacologically inhibiting D1R in the NAc leads to decreased ethanol 
consumption [271], blocked behavioral sensitization to ethanol [272], and reversal of ethanol-
induced changes to GABAA receptor-mediated tonic currents [273]. These studies indicate that 
ethanol preferentially modulates D1R MSNs, but studies are lacking on gene expression and 
chromatin regulation that may underlie mechanisms of ethanol in this cell type. 
Improved rodent models that better replicate some aspects of human drinking have 
recently been developed. In particular, Howard Becker’s group developed a chronic ethanol 
exposure model in mice that escalates ethanol drinking three days following vapor ethanol 
exposure [184,274,275]. The procedure relies on four cycles of vapor ethanol and withdrawal, 
which increases ethanol drinking in a limited access paradigm up to 80 hours following the final 
ethanol vapor session. Studies have recently implicated changes to glutamate levels and 
neurophysiology in the NAc induced by this paradigm [184,276]. Additionally, long-lasting 
effects of ethanol suggest changes in gene expression and chromatin remodeling also underlie 
drinking escalation. Based on research implicating D1R MSNs in mediating the effects of 
ethanol as well as changes in the NAc after chronic vapor ethanol exposure, we chose to study 
the effects of chronic intermittent vapor ethanol on gene expression and chromatin regulation in 
D1R MSNs of the NAc. This study tests the hypothesis that chronic ethanol exposure and 
withdrawal induces dynamic changes in gene regulation via discrete histone modifications in 
accumbal D1R MSNs. 
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4.2 MATERIALS AND METHODS 
A step-by-step protocol for NAc dissociation and RNA and ChIP protocols is provided in 
Appendix A. 
4.2.1 Animals and treatment 
All experiments were approved by the Institutional Animal Care and Use Committee of the 
University of Pittsburgh and conducted in accordance with the National Institutes of Health 
Guidelines for the Care and Use of Laboratory Animals. Two heterozygous transgenic males 
containing a gene for the tdTomato fluorescent protein driven by the D1R promoter were 
purchased from the Jackson Laboratory (Stock #016204). These males were bred to isogenic 
C57BL/6J females and offspring were checked for the presence of the transgene with PCR after 
weaning. Male offspring that possessed the transgene were housed with their wild type 
littermates and used for all experiments. Mice were housed under 12 hour light/dark cycles and 
had ad libitum access to food and water. 
 Transgenic mice were used for experiments at 8-10 weeks of age. The experimental 
design is summarized in Fig. 21. Briefly, mice were weighed and injected with either 1 g/kg of 
10% ethanol solution in saline (0.01 ml/g) (ethanol-treated) or 0.01 ml/g saline (room air 
controls). Mice were immediately placed into one of two identical custom-built vapor chambers 
described in Section 2.2.2 that were used to deliver either room air or vaporized ethanol. Flow 
rate, vaporization temperature, and exposure time were optimized to achieve consistent BECs 
without the use of pyrazole. Room air was flowed into two heated Erlenmeyer flasks at a rate of 
7.5 L/min; one flask received ethanol at a rate of ~80 μl/min while the other flask received no 
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ethanol. Air from the ethanol and control flasks flowed into separate chambers so that only one 
chamber received vaporized ethanol. Mice were housed for 16 hours in the chambers from 17:00 
to 09:00. At the end of the first exposure, tail blood was collected and used to analyze BECs. 
From 09:00 to 17:00, mice were placed back onto a ventilated cage rack and only exposed to 
room air. 
 Injections and exposures were done on 4 consecutive nights and mice were sacrificed 
either immediately following the 4th exposure (chronic ethanol group) or 72 hours following the 
4th exposure (72 hour withdrawal) (Fig. 21); room air controls from both cohorts were included 
in this study. Any mouse that exhibited an anesthetic effect of ethanol intoxication was excluded 
from the experiment. 
4.2.2 PCR genotyping 
Tail snips (< 0.5 cm) were taken at the time of weaning and DNA was extracted using the 
DNeasy Blood and Tissue Kit (Qiagen) according to the manufacturer’s instruction. DNA was 
used for a PCR assay containing GoTaq HotStart Polymerase (Promega, Madison, WI), primers 
for the transgene and positive control region (20 μM), dNTPs (2.5 mM), 5x reaction buffer, and 
MgCl2 (2.5 mM). Primer sequences used were Transgene, F: 5’-CTT CTG AGG CGG AAA 
GAA CC-3’ and R: 5’-TTT CTG ATT GAG AGC ATT CG-3’, Positive control region, F: 5’-
CTA GGC CAC AGA ATT GAA AGA TCT-3’ and 5’-GTA GGT GGA AAT TCT AGC ATC 
ATC C-3’. PCR conditions were 3 min at 94˚ C, then 30 s at 94 ˚ C, 1 min at 59 ˚ C, 1 min at 72 
˚ C repeated 35 times, then 2 min at 72 ˚ C. PCR products were run on a 1.5% agarose gel. 
Transgenic animals were identified by the presence of two bands: a 750 bp band for the 
transgene and 324 bp band for the positive control region. 
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4.2.3 Dissociation of the nucleus accumbens into a single cell suspension 
Tissue dissociation was adapted from a previous report of FACS using BAC transgenic mouse 
strains [277]. The following reagents were made fresh before the start of each experiment. 
HABG: 200 μl of 50x B27 supplement (Life Technologies) and 25 μl of 100x Glutamax (Life 
Technologies) into 9.8 ml of Hibernate A cell culture media (Life Technologies). Papain 
dissociation buffer: 14 μl of 100x Glutamax (Life Technologies) into 5.5 ml Hibernate E cell 
culture media (BrainBits LLC, Springfield, IL). Papain: 5 ml of papain dissociation buffer into 
one vial containing 100 U of papain (Worthington Biochem, Lakewood, NJ). DNase: 500 μl of 
papain dissociation buffer into one vial containing 1000 U of DNase (Worthington Biochem). 
 Adult animals were sacrificed by cervical dislocation at the time points indicated (Fig. 
21). The brain was extracted and placed into an ice cold adult mouse brain slicer matrix with 1 
mm coronal section slice intervals (Zivic Instruments). The NAc was identified under a 
dissecting microscope as the region surrounding the anterior commissure; it was differentiated 
from the overlying dorsal striatum by its homogenous appearance relative to the striated 
appearance of the dorsal striatum. The NAc was placed into a small culture dish containing 1 mL 
HABG supplemented with 100 U/ml of RiboLock RNase inhibitor (Thermo Scientific, Waltham, 
MA). Tissue was cut into ~1 mm3 pieces using a scalpel. Tissue pieces were gentled aspirated 
using a cut 1 ml pipet tip and allowed to fall to the edge of the tip. The pipet tip was placed into 2 
ml of Papain supplemented with 110 μl DNAse that was pre-warmed to 37˚ C and the tissue 
pieces were allowed to gently fall into the Papain so that there was minimal transfer of HABG 
into Papain. Tissue pieces in Papain were covered in aluminum foil and incubated at 32˚ C with 
gentle rotation for 15 minutes. 
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After incubation in Papain and DNase, tissue pieces were collected with a cut 1 ml pipet 
tip and allowed to fall to the edge of the tip. The pipet tip was placed into 2 ml of HABG 
supplemented with 100 U/ml of RiboLock RNase inhibitor and the tissue pieces were allowed to 
gently fall into the Papain so that there was minimal transfer of Papain into HABG. The tissue 
pieces in HABG were covered with aluminum foil and incubated for 5 minutes at room 
temperature. Tissue pieces were triturated using a latex pipette bulb and autoclaved, cotton-
plugged Pasteur pipette that was fire-polished to a ~0.5 mm tip. For trituration, tissue pieces in 
HABG were sucked into the pipette and ejected over ~5 seconds until large tissue pieces were no 
longer visible, which usually took ~10 cycles of trituration. Care was taken to avoid air bubbles 
in the cell suspension. 
The dissociated cell suspension was passed through a 70 μm cell strainer (Fisher 
Scientific, Pittsburgh, PA) by aspirating 800 μl of solution at a time through a cut pipet tip and 
gently placing the tip over the cell strainer. After the cell suspension was strained, 5 ml of 
HABG supplemented with 100 U/ml of RiboLock RNase inhibitor was passed over the same cell 
strainer. Therefore, the total volume of the cell suspension was ~7 ml. The cell suspension was 
covered in aluminum foil and immediately transported for cell sorting. It is important to note that 
this process takes ~45 minutes from the time the animal is sacrificed to cell sorting. 
4.2.4 Fluorescence activated cell sorting of tdTomato+ cells 
Neurons were sorted in collaboration with the Rheumatology Flow Cytometry Core Facility at 
the University of Pittsburgh. Briefly, the dissociated cell suspension was sorted on a FACS 
ARIA II (Becton Dickinson Inc.) using an 85 μm nozzle with a pressure of 45 p.s.i. debris and 
doublets in the sample were excluded from sorting by gating for intact cells using forward and 
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side scatter profiles. tdTomato was excited by an argon-ion laser (488 nm) and detected using an 
emission spectra between 564 nm and 606 nm. Fluorescence gating thresholds were established 
by sorting wild-type animals that do not express tdTomato and isolating events that were above 
the highest detectable limit in wild type animals (Fig. 22). tdTomato+ and tdTomato- cells were 
separated using fluorescence gating and collected into two separate tubes. 
4.2.5 RNA extraction 
For RNA studies, cells were sorted directly into 750 μl of Trizol LS (Invitrogen). After sorting, 
volume of Trizol LS with sorted cells was measured and nuclease free water was added to bring 
the volume up to 1 ml. RNA was extracted using the RNeasy mini kit (Qiagen) according to the 
manufacturer’s protocol without DNase digestion and eluted in 30 μl of nuclease free water. 
4.2.6 RT-qPCR 
RNA was converted into cDNA using RT (Bio-Rad, Hercules, CA). Reactions were carried out 
in duplicate for each gene. SYBR green fluorescent master mix (Bio-Rad) was added to each 
well and visualized using a Bio-Rad iCycler. All primers were optimized for 90% to 110% 
efficiency at the following conditions: 10 min at 95˚C followed by 40 cycles of 30 s at 95˚C, 1 
min at 60˚C, and 30 s at 72˚C. Primer sequences used were β-actin, F: 5’-TCA TGA AGT GTG 
ACG TTG ACA TCC GT-3’ and R: 5’-CCT AGA AGC ATT TGC GGT GCA CGA TG-3’, 
D1R, F: 5’-GAA CCC AGA AGA CAG GTG GA-3’ and R: 5’-GCT TAG CCC TCA CGT TCT 
TG-3’, Glial Fibrillary Acidic Protein (GFAP), F: 5’-AGA AAA CCG CAT CAC CAT TC-3’ 
and R: 5’-TCA CAT CAC CAC GTC CTT GT. Threshold cycle (Ct) values were calculated for 
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each well and duplicate values averaged. The difference between specific genes and β-actin 
(ΔCt) was calculated for each animal and normalized to the average of room air sired offspring 
(ΔΔCt). Fold change over room air sired offspring was calculated for each animal using the 
following formula: 2-ΔΔCt. 
4.2.7 Native FACS-ChIP 
Reaction buffers were adapted from a previous report of low cell number ChIP [278]. To prevent 
histone deacetylation and protease activation during tissue dissociation for ChIP studies, all 
media and buffers were supplemented with 5 mM sodium butyrate and, beginning after papain 
treatment, all media and buffers were supplemented with cOmplete protease inhibitor cocktail 
(Roche, Basel, Switzerland). Cells were sorted directly into 250 μl of 2x micrococcal nuclease 
(MNase) buffer (100 mM Tris, pH 8.0, 2 mM CaCl2, 0.4% Triton X-100) and volume was 
measured and brought up to 500 μl by adding nuclease free water. MNase (New England 
Biolabs, Ipswich, MA) was diluted by adding 1 μl of MNase (2,000 gel units) to 500 μl 1x 
MNase buffer (50 mM Tris, pH 8.0, 1 mM CaCl2, 0.2% Triton X-100). For MNase digestion of 
chromatin, 15 μl of diluted MNase was added to sorted cells and cells were incubated in a 37˚ C 
heat block for 5 minutes. To stop the MNase digestion, 50 μl of 10x MNase stop buffer (110 mM 
Tris, pH 8.0, 55mM EDTA) was added to the cells. From this point, chromatin was kept on ice 
or in a 4˚ C room through immunoprecipitation. To lyse cells, 550 μl of ice cold 2x RIPA cell 
lysis buffer (280 mM NaCl, 1.8% Triton X-100, 0.2% SDS, 0.2% Na Deoxycholate, and 5 mM 
EGTA) was added. The solution was mixed by inverting the tube and the tube was left on ice for 
15 minutes. To remove cell debris, the tube was centrifuged at 4˚ C at 13,000 rpm for 10 
minutes. Chromatin was decanted into a new 1.5 ml Eppendorf tube and placed on ice. 
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 Chromatin was divided into two 400 μl aliquots for immunoprecipitation and one 200 μl 
aliquot used as input. For immunopreciptiation reactions, 22 μl of MagnaChIP Protein A/G 
magnetic beads (Millipore, Billerica, MA) were added to each tube. To one tube, 5 μl of an anti-
H3K27me3 antibody (#17-622, Millipore) was added and to the other tube 9 μl of an anti-
H3K18ac antibody (#9675, Cell Signaling Technology, Danvers, MA) was added. As a negative 
control for optimization experiments, nonspecific IgG antibody (#PP64B, Millipore) was also 
used.  The immunoprecipitation tubes were incubated at 4˚ C with gentle end-over-end rotation 
for 3.5 hours while the input tube was kept at 4˚ C with no rotation. After incubation, tubes were 
placed onto a magnetic rack and the supernatant was removed using a pipet. Magnetic beads 
were washed 3 times with 500 μl RIPA buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 140 mM 
NaCl, 1% Triton X-100, 0.1% SDS, 0.1% Na Deoxycholate) and 1 time with 500 μl TE buffer 
(10 mM Tris, pH 8.0, 1 mM EDTA); between washes, the beads were incubated for 5 minutes at 
4˚ C with gentle end-over-end rotation and the supernatant was removed using a pipet. 
 Following the TE wash step, magnetic beads were eluted in 200 μl elution buffer (50 mM 
NaCl, 20 mM Tris, pH 8.0, 5 mM EDTA, 1% SDS, 50 μg/ml proteinase K); for the input, 
proteinase K was added to a concentration of 50 μg/ml. The magnetic beads in elution buffer and 
input were incubated at 65˚ C with gentle rotation for 45 minutes. Following proteinase K 
digestion, tubes were briefly spun on a tabletop centrifuge and placed into a magnetic rack. The 
supernatant (200 μl) was transferred to a tube containing 10 μl 3 M Na Acetate and 1 ml buffer 
PB (Qiagen). DNA was purified using the Qiagen MinElute Reaction Cleanup Kit according to 
the manufacturer’s protocol and eluted in 14 μl nuclease free water.  
 ChIP DNA samples were quantified using a Qubit fluorometer (Life Technologies). For 
optimization of FACS-ChIP experiments using tdTomato+ neurons, samples were diluted to 30 
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μl and 5 μl were analyzed by ChIP-qPCR in duplicate for each primer set. qPCR conditions were 
the same as reported in the RT-qPCR section. Primer sequences used were: D1R promoter, F: 5’-
GCC TCT GGT TTC CTA CAC CC-3’ and R: 5’-AGG GAA AAG CAT GGT CGA GG-3’, 
GFAP promoter, F: 5’-ACA AAA GGC CTG GGT TGA CA-3’ and R: 5’-CTC TGG ATC TGG 
AAC TCG CC-3’, LINE1 5’ UTR, F: 5’-CCG GGA CTC CAA GGA ACT TA-3’ and R: 5’-
CCT CCT GGC CGA AGA AGA-3’. Ct values for antibodies were normalized to the input Ct 
value for each primer set. Data are present as fold enrichment over input DNA. 
4.2.8 RNA expression microarray 
RNA collected from chronic ethanol and room air controls (n = 7/group) as well as 72 hour 
withdrawal and room air controls (n = 4-5/group) was sent to Dr. R. Adron Harris’ lab at the 
University of Texas—Austin. RNA concentration and RNA integrity numbers (RIN) were 
determined on an Agilent Bioanalyzer using the Eukaryotic Total RNA Nano Series II kit 
(Agilent Technologies, Santa Clara, CA). The EpiCentre TargetAmp Pico 2-round amplification 
kit (Illumina, San Diego, CA) was used to amplify 180 pg of RNA. cRNA expression will be 
analyzed using the Illumina mouse WG6 v2 whole genome expression array. 
4.2.9 Statistics 
For RT-qPCR, a Student’s t-test was used to compare groups. For ChIP-qPCR, a two-way 
ANOVA with Bonferroni post-hoc testing was used to compare antibody enrichment. Statistical 
significance was defined by a p-value < 0.05. All data are presented as mean +/- SEM. 
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4.3 RESULTS 
4.3.1 Chronic intermittent ethanol exposure 
Mice were injected with either 1 g/kg ethanol or saline and exposed to vapor ethanol or room air, 
respectively, overnight for 4 consecutive days (Fig. 21). BECs were measured after the first 
exposure and averaged 231.7 +/- 12.7 mg/dl (mean +/- SEM). 
 
Figure 21. Chronic intermittent vapor ethanol exposure 
Chronic intermittent vapor ethanol exposure escalates ethanol drinking in a limited access drinking 
assay [274]. Mice were injected with either 1 g/kg ethanol or saline and placed into a chamber 
receiving either vapor ethanol or room air, respectively, for 16 hours. After 16 hours, all mice 
were placed back into a ventilated cage rack for 8 hours. Mice received four cycles of exposure 
over consecutive days and were either sacrificed immediately (chronic ethanol or room air) or 72 
hours following the final exposure (72 hour withdrawal or room air). 
4.3.2 FACS of tdTomato+ neurons 
Cells were sorted by their size based on forward and side scatter profiles to exclude debris and 
doublets; additionally, they were sorted based on tdTomato intensity (Fig. 22). A distinct group 
of cells with high tdTomato expression could clearly be discriminated using FACS. For RNA 
collection, there were no significant differences in average number of cells collected between the 
chronic ethanol (n = 7; 24143 +/- 2703, mean +/- SEM) and room air control (n = 7; 28429 +/- 
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3032, mean +/- SEM) groups as well as the 72 hour withdrawal (n = 5; 24900 +/- 3508; mean +/- 
SEM) and 72 hour room air control (n = 5, 35720 +/- 4580, mean +/- SEM) groups.  
 
Figure 22. FACS of D1R::tdTomato cells from BAC transgenic mice 
A dissociated neuronal suspension derived from the NAc of a BAC D1R::tdTomato transgenic 
mouse was sorted on a FACS Aria II. (A) Neurons were selected by Forward and Side Scatter 
profiles. Fluorescence gates were established by comparing tdTomato intensity in (B) wild type 
and (C) D1R::tdTomato mice. Purple cells were denoted as tdTomato+ and collected for analysis. 
4.3.3 RNA analysis 
Optimization of cell sorting indicated that the cell population was enriched in D1R with almost 
undetectable levels of GFAP; therefore, tdTomato+ cells likely represent D1R MSNs (Fig. 23). 
 RNA was collected from FAC-sorted neurons after ethanol or room air exposure and sent 
to Dr. R. Adron Harris’ lab at UT-Austin for whole genome expression analysis. There, it was 
quantified and assessed for quality using the Agilent Bioanalyzer. RNA integrity numbers (RIN) 
were used to determine RNA quality based on height of 28s and 18s ribosomal subunit peaks 
[279]. RIN values below 7 are associated with poor performance on gene expression microarrays 
[280]; importantly, all samples had RIN values greater than 7 (Fig. 24A). For the 24 samples 
collected for whole genome expression analysis, RNA recovery averaged 43.7 +/- 4.0 ng (mean 
+/- SEM) (range: 13.5 ng – 80.6 ng) with no differences between groups (Fig. 24A). There was a 
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near-significant trend for a correlation between cells collected and RNA yield (r = 0.38, p = 
0.06). In preparation for the Illumina mouse WG6 v2 whole genome expression array, 180 pg of 
RNA was amplified using the EpiCentre TargetAmp Pico 2-round amplification kit (Fig. 24B). 
All RNA has been amplified and is currently in queue for the whole genome expression array. 
 
Figure 23. tdTomato+ cells are enriched in D1R and lack GFAP expression 
Using RT-qPCR, tdTomato+ were found to have (A) 40-fold enrichment of the Dopamine D1 
receptor (n = 8/group) and (B) nearly undetectable expression of GFAP (n = 3/group). *p < 0.05. 
 
 
Figure 24. Example of FACS RNA analysis and amplification 
RNA was collected form FAC-sorted neurons following ethanol or room air exposure. (A) Agilent 
Bioanalyzer analysis of RNA indicated strong ribosomal peaks (dark bands) and RIN values above 
7. Lanes: A1 is a negative control (water), B1-E1 are D1R-derived RNA, F1 is a positive control 
(RNA derived from HeLa cells), G1 is a ladder, and H1-D2 are D1R-derived RNAs. (B) RNA 
(180 pg) from each sample was used for 2-step cRNA amplification in preparation for Illumina 
mouse WG6 v2 whole genome expression array; peak size of cRNA was ~600 bp across all 
samples; lanes are indicated above, where numbers correspond to the sample (CE = chronic 
ethanol; RA = room air; 72 = 72 hour ethanol withdrawal; RA72 = room air 72 hour withdrawal). 
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4.3.4 Chromatin analysis 
Chromatin was collected from sorted tdTomato+ cells and digested using MNase. Chromatin 
was left in its native state and immunprecipitated immediately, so that there were no freeze-thaw 
cycles. Optimization using several antibodies revealed that anti-H3K18ac and anti-H3K27me3 
antibodies could be used to discriminate active and repressed gene promoters (Fig. 25). Notably, 
H3K18ac is enriched at actively transcribed gene promoters while H3K27me3 is a component of 
the polycomb repressive complex and associated with transcriptional repression [247]. To test 
enrichment of D1R MSNs, H3K18ac and H3K27me3 levels were measured relative to input at 
the D1R and GFAP promoters, which were enriched and repressed, respectively, based on RT-
qPCR analysis of this cell type (Fig. 23). Therefore, the D1R promoter should have high levels 
of histone acetylation and low levels of histone methylation while the GFAP promoter should 
have the opposite pattern. The long interspersed nuclear element (LINE1) 5’ UTR was used as a 
control that could be easily quantified, since there are ~500,000 loci for this retrotransposable 
element in the genome and it is normally associated with histone methylation [247,281]. 
 Using H3K18ac, H3K27me3, and nonspecific IgG antibodies, DNA quantity was 
assessed relative to input using qPCR. There was a significant interaction between histone 
modification and promoter regions studied (F(4,13) = 14.45, p < 0.0001) (Fig. 25). Bonferroni 
post-hoc testing revealed significantly increased levels of H3K27me3 relative to H3K18ac at the 
(n = 4; p < 0.001) and the GFAP promoter (n = 2; p < 0.05); conversely, there were increased 
levels of H3K18ac relative to H3K27me3 at the D1R promoter (n = 3; p < 0.05) (Fig. 25). 
Additionally, there were nearly undetectable levels of DNA relative to input using a nonspecific 
IgG antibody, indicating specificity for the histone modifications studied (Fig. 25). DNA was 
also quantified by the Genomics and Proteomics Core Laboratory at the University of Pittsburgh 
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using the Qubit fluorometer (Life Technologies) and could be detected in the input as well as 
anti-H3K18ac, and anti-H3K27me3 immunoprecipitations; no DNA was detected using the IgG 
antibody. These data indicate that ChIP can be used to discriminate active and repressed genomic 
regions in FAC-sorted neuronal subtypes with low variability between animals. 
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Figure 25. ChIP using FAC-sorted tdTomato+ cells from BAC transgenic animals 
tdTomato+ cells were collected from D1R::tdTomato BAC transgenic mice and used to analyze 
histone occupancy at gene promoters. There was a significant increase in H3K27me3 levels 
relative to H3K18ac levels at the repressed retrotransposable element LINE1 (n = 4) and GFAP 
promoter (n = 2). Conversely, there was a significant increase in H3K18ac levels relative to 
H3K27me3 at the D1R promoter (n = 3). For the IgG antibody, there was nearly undetectable 
signal of LINE1 (n = 2), D1R (n = 1), or GFAP (n = 1) promoter regions, suggesting specificity of 
the H3K18ac and H3K27me3 antibodies.  *p < 0.05, ***p < 0.001 
4.4 DISCUSSION 
This section describes optimization of RNA extraction for whole genome expression and 
chromatin analysis in a neuronal subtype collected from a BAC transgenic mouse strain. Using 
FACS, ~25,000 tdTomato+ cells were collected from the NAc with minimal tissue processing 
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time (~45 min), providing sufficient RNA and chromatin for downstream analysis. Importantly, 
this may be the first description of a ChIP protocol for neuronal subtypes that were sorted by 
FACS using BAC transgenic strains. While results of ethanol-induced gene regulation in this cell 
type are pending, experimental validation shows that tdTomato+ cells have 40-fold enrichment 
of D1R relative to tdTomato- cells with nearly undetectable expression of GFAP, indicating cell 
type specificity for D1R MSNs. Despite low input for traditional chromatin studies, the ChIP 
protocol optimized in this study discriminated transcriptionally active and repressed regions on 
the basis of H3K18ac and H3K27me3 levels at gene promoters. Importantly, it showed elevated 
histone acetylation the D1R promoter in tdTomato+ cells, indicating cell type specificity at the 
level of chromatin. The discussion will be limited to experimental considerations and 
interpretation of potential effects of chronic intermittent ethanol exposure on this cell type. 
FAC-sorting of the NAc from D1R::tdTomato BAC transgenic mice was efficient, with a 
distinct population of cells with high tdTomato expression (Fig. 22). Gene expression and 
chromatin analysis of the D1R promoter in these cells confirmed that these are highly enriched 
D1R MSNs. While collection of ~25,000 tdTomato+ cells per sort is a substantial improvement 
over previous studies using BAC transgenic stains [258,259,277], this amount is much smaller 
than the total population of D1R MSNs in the NAc, suggesting considerable loss of neurons 
during tissue processing. Improving yields will likely require optimization of tissue trituration, 
which induces considerable mechanical stress on cells and is likely the greatest source of cell 
loss. Unfortunately, neuronal FACS studies are still limited, so there are no reports of how 
changing experimental parameters affects yield. Identifying optimal sorting conditions will 
improve downstream analysis by providing more input for RNA and chromatin studies. 
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The FACS protocol developed for this study was able to provide sufficient and high 
quality (RIN > 7) RNA for whole genome expression microarray analysis. This has been 
demonstrated previously [55,258,259]; however, it is notable that in this study, compared to 
other FACS whole genome expression studies, RNA yields for the majority of samples collected 
were sufficient for one-round amplification (> 25 ng input) (Fig. 24) [258,259,261]. While one- 
and two-round amplification generate gene expression levels that correlate well with one another 
[282], using one-round amplification increases the number of transcripts detected [282]. 
Therefore, since this study used a two-round amplification procedure, it may be limited to 
detecting changes in expression of highly expressed transcripts in D1R MSNs. Using an RNA 
collection kit optimized for elution in a small volume would have increased the concentration of 
sample collected, but it may have also reduced yield. Therefore, it is unclear whether changing 
the RNA collection protocol would allow for one-round amplification. While the current study is 
sufficiently powered to detect ethanol-induced changes in gene expression, further optimizing 
RNA collection may improve detection of gene transcripts by allowing for one-round cRNA 
amplification. 
The goal of this study is to examine the dynamics of ethanol-induced histone 
modifications with high sensitivity by using a specific cell type enriched by FACS. Our 
optimization experiments show that genomic regions with differential expression in D1R MSNs 
can be discriminated based on H3K18ac and K3K27me3 levels (Fig. 25). Importantly, this study 
demonstrates that histone modification levels are detectable with low variability after cell sorting 
using the current protocol. Therefore, we are poised to examine whether chronic intermittent 
ethanol exposure induces long-term changes to chromatin that could underlie its effect on 
ethanol drinking escalation [274]. Pending results from the RNA microarray will be used to 
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identify genes whose expression is altered by ethanol immediately and 3 days following 
exposure. Then, ChIP will be used to study the balance of H3K18ac and H3K27me3 at 
differentially expressed gene promoters. This method will uncover dynamic mechanisms of 
ethanol-induced gene regulation in D1R MSNs by identifying the time course of ethanol-induced 
epigenetic modifications. It will be especially interesting to identify long-term, ethanol-induced 
changes in chromatin despite no detectable changes in expression. Importantly, this is a proof of 
principle study, so that in the unlikely event we do not identify any ethanol-induced changes to 
levels of H3K18ac and H3K27me3 at gene promoters, this study appears to be the first to 
develop a ChIP protocol for highly specific BAC transgenic strains. Therefore, while D1R MSNs 
are clearly modified by ethanol and critical for goal-oriented behavior like ethanol drinking 
[267,273] our protocol is scalable to other cell types or histone modifications that may be more 
relevant for ethanol action. 
In conclusion, this section describes a method for isolating D1R MSNs with high 
specificity and studying whole genome expression using a microarray as well as histone 
modifications using ChIP. Future studies will identify the role of chronic intermittent ethanol and 
withdrawal on gene regulation in this cell type in vivo. 
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5.0  FINAL DISCUSSION 
5.1.1 Conclusions and significance 
Despite the well-studied effects of ethanol on gene expression, little is known about mechanisms 
by which ethanol alters chromatin to regulate gene promoters. Moreover, it is not known whether 
ethanol induces long-lasting effects on chromatin that are associated with changes in ethanol 
drinking and whether ethanol-induced epigenetic modifications are heritable. Therefore, the 
experiments in this thesis tested three distinct hypotheses related to identifying epigenetic effects 
of ethanol: 1) paternal ethanol exposure regulates ethanol drinking and ethanol-related behavior 
in offspring; 2) acute ethanol induces conserved changes to histone modifications at model gene 
promoters in CCx; 3) chronic intermittent vapor ethanol and withdrawal induce dynamic changes 
in gene regulation via discrete histone modifications in accumbal D1R MSNs. The results 
presented in this thesis provide evidence for epigenetic effects of ethanol in mediating both 
heritability of ethanol drinking and sensitivity to ethanol as well as ethanol-induced gene 
regulation in CCx. Additionally, they set up future studies of ethanol’s epigenetic mechanisms in 
neuronal subtypes, which will increase sensitivity of current assays to detect cell-specific 
changes in gene regulation. 
 Heritability of AUD has been extensively studied and several mutations in alcohol 
metabolizing enzymes are associated with risk for developing AUD [17-19]; however, GWAS 
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has failed to uncover genetic variants that explain more than a fraction of a percent of risk for 
AUD [21]. Therefore, searching for alternative explanations to explain missing heritability is an 
important step toward uncovering mechanisms of how risk for AUD is inherited. Importantly, 
dozens of studies have now uncovered metabolic and behavioral effects of parental 
environmental manipulations on offspring (presented in Section 1.2.3). Additionally, several of 
these have associated offspring behavioral changes with transmission of epi-alleles, which 
include altered histone modifications, DNA methylation, and/or sncRNA populations in gametes 
[77,96,98]. Considering epimutagenic effects of ethanol and reports of altered behavior in 
offspring of ethanol-exposed animals (presented in Section 1.3.4), it is not completely surprising 
that paternal ethanol exposure altered ethanol drinking and ethanol-related behaviors in offspring 
in this study. 
 To identify mechanisms mediating paternal ethanol’s effects on offspring, it is important 
to consider what is currently known about mechanisms of epigenetic inheritance. While the field 
is still relatively new, several potential mechanisms underlying epigenetic inheritance have been 
proposed in mammals. In particular, Wolf Reik’s group identified large regions of DNA 
surrounding IAPs, a type of retrotransposable element in mice, that escape genomewide 
demethylation during development [74]. Another recent study identified nearly 5,000 paternally 
imprinted DMRs in sperm that also retain their DNA methylation levels during genomewide 
demethylation [283]. DNA methylation at these regions can affect offspring phenotype. Two 
studies have found that DNA methylation patterns at gene promoters regulating coat color [109] 
and tail kinking [108] are inherited by offspring. Considering DNA methylation levels are 
maintained between cell divisions [42], these studies provide evidence for mitotic and meiotic 
heritability of this mark, which is a critical aspect of a modification that must survive rounds of 
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cell divisions following fertilization to be maintained in adult offspring. These features have led 
several groups to study how parental exposures alter the DNA methylation landscape in 
offspring [84,87,89,92,96]. This study also found a change in DNA methylation at the Bdnf 
promoter in sperm that was maintained in the brains of offspring. Therefore, it will be important 
to characterize DNA methylation at other genes whose expression is altered by paternal ethanol. 
 Other sources of epi-alleles in gametes are also important to consider. Sperm have a 
small population of RNAs (~10 fg/sperm) that appear to have an important role in development. 
Direct mechanisms of RNA-mediated epigenetic inheritance are emerging. One study identified 
an intronic insertion in the c-kit gene that led to a white tail and feet phenotype in mice, which 
was inherited even without inheritance of the intron; interestingly, the phenotype could be 
replicated by injecting RNA derived from the intronic insertion into the pronucleus [76]. A 
recent study of paternal stress also found that injecting sperm-derived miRNAs from stressed 
sires into an embryo could replicate its effect on offspring [77]. Semen is also a large source of 
cell-free RNAs that exist in vesicles and are stable up to 24 hours in solution [284], though their 
function is still unknown. Additionally, retained histones in sperm have a critical role in early 
offspring development [102,104]. However, several questions remain regarding heritability of 
sperm-derived RNAs and histones. Mainly, how is a small population of RNAs or retained 
histones transferred between rapid cell divisions in early development? The studies above 
suggest that they are and it will be important to characterize the effect of ethanol on sperm-
derived RNAs and retained histones, as they are likely to affect offspring development. 
 In Section 2 of this dissertation, paternal ethanol exposure was associated with decreased 
ethanol drinking and increased sensitivity to ethanol in male offspring using a mouse model. 
Chronic ethanol was also associated with a modest reduction in DNA methylation at the 
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paternally imprinted IG DMR and the Bdnf promoter in motile sperm as well as the Bdnf 
promoter in offspring VTA. These studies introduce the idea that parental ethanol consumption 
can alter ethanol-related behaviors in the next generation. While this finding is surprising, it is 
important to place its effect in context with its magnitude. The 2 bottle choice drinking 
experiment required a relatively large number of male offspring (n = 17/group) (Fig. 7) to 
uncover a statistically significant effect on ethanol preference and consumption. This finding 
suggests that penetrance or heritability of epi-alleles is much lower than 100%, which is also 
implied by analyzing individual clones used in bisulfite sequencing results that show some 
gametes have no changes to DNA methylation after ethanol exposure (Fig. 3 and Fig. 15). While 
it is possible that ethanol’s effects on DNA methylation in sperm are not necessary for its effects 
on offspring behavior, these results may also be explained by recent findings in humans. 
Specifically, variable inheritance of epi-alleles is supported by human studies of colorectal 
cancer, which indicate some but not all offspring inherit altered DNA methylation at a promoter 
region for a mismatch repair enzyme that confers risk for colorectal cancer [285]. Though 
mechanisms that underlie susceptibility to epigenetic inheritance are unknown, their impact on 
human behavior may be large even if the number of susceptible individuals is small. In reference 
to this study, the lifetime prevalence of AUD is 42% among men [8], so that if the results apply 
to humans at any level they are likely to have a meaningful impact on drinking behavior. 
 Another important aspect of the study presented in Section 2 of this dissertation is its 
potential to uncover biomarkers associated with resistance to ethanol consumption. Despite not 
identifying an increase in ethanol drinking in ethanol-sired offspring as hypothesized, studying 
mechanisms that decrease ethanol consumption in this cohort may have greater impact.  Notably, 
ethanol consumption among 129xC57 offspring in this study was variable – with some mice 
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drinking nearly no ethanol and others drinking only ethanol versus water. More male offspring 
had low ethanol preference in the ethanol-sired group, which contributed to a group effect for 
decreased preference. The data hint at a mechanism that may protect some male offspring from 
high ethanol drinking. Ethanol-sired male offspring had increased Bdnf expression and both male 
and female offspring had a modest reduction in DNA methylation at the Bdnf promoter. While 
the findings between Bdnf expression and ethanol consumption are only correlative and DNA 
methylation changes are present in both sexes, several studies suggest Bdnf may be playing a role 
in this phenotype. Intra-VTA infusion of Bdnf enhances sensitivity to cocaine [203] and 
amphetamine [204] as well as decreases morphine seeking behavior [205]. Moreover, increased 
Bdnf expression in other brain regions is associated with decreased ethanol drinking [188-190]. 
A genomewide study of epigenetic reprogramming during early development suggests that DNA 
methylation at the Bdnf promoter remains relatively constant throughout this process [74]. These 
studies support a role for Bdnf in our phenotype, though it remains to be seen if epigenetic 
regulation of Bdnf plays a causative role. Establishing a causative role would likely require 
modulating Bdnf signaling, possibly through use of a TrkB receptor antagonist like ANA-12 
[98], and testing offspring on ethanol drinking and ethanol-related behavior assays.  
 Section 3 of this dissertation studied general mechanisms of ethanol that regulated gene 
expression in CCx and HC. The study was able to identify several epigenetic mechanisms of 
ethanol, including decreased expression of Hdac2 and Hdac11 (Fig. 19) and increased H3K4me3 
in CCx (Fig. 18) as well as increased histone acetylation in HC (Fig. 20). Additionally, despite 
decreased expression of HDACs, the study identified histone deacetylation at down-regulated 
gene promoters in CCx (Fig. 16), indicating that some HDAC activity is important for ethanol-
induced gene regulation. However, inability to identify conserved epigenetic mechanisms at gene 
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promoters indicates that acute ethanol has complex mechanisms, likely relying on cell-type and 
gene-specific specific induction of transcription factors across a range of secondary mechanisms. 
By highlighting the complexity of ethanol action, this study indicates that targeting chromatin 
modifying enzymes, including HDAC inhibitors, in treatment of AUD may have variable effects 
on ethanol-related behaviors. This idea is also indicated by published studies to date that show 
varied roles of HDAC inhibitors on ethanol drinking and behavioral sensitization [139,142-144] 
(presented in section 1.3.2). Finally, while the study did not identify a conserved ethanol-induced 
epigenetic program, it is possible that one may be discovered with larger-scale studies of histone 
modifications or in vitro studies of single cell types.  
 Based on challenges of studying a diverse tissue type at one time point in Section 3, we 
attempted to focus epigenetic studies of ethanol on a single cell type of the NAc in Section 4. 
This study required developing a novel ChIP protocol to study chromatin from a relatively small 
number of cells isolated by FACS. While several groups have reported studying gene expression 
from FAC-sorted neuronal subtypes, being able to use ChIP to study induction of histone 
modifications at gene promoters is potentially a major step toward understanding how neuronal 
subtypes adapt to their environment. Importantly, this type of dynamic, cell-specific data is being 
endorsed by the recently proposed NIH Brain Initiative [286], so that it may be relevant to 
several fields in neuroscience. It may be especially relevant for addiction research, since drugs of 
abuse modulate several neurotransmitter systems to program the brain into a state of drug-
seeking behavior [28]. Uncovering which of these is most sensitive to drug-induced gene 
regulation may allow for more targeted approaches to modify addictive behaviors. Since the 
ChIP protocol developed in this study is adaptable to potentially any BAC transgenic strain or 
 101 
virally-transfected fluorescent protein reporter and histone modification, it has potential 
significance for uncovering a broad range of epigenetic mechanisms in neuronal subtypes. 
 Specific mechanisms that underlie the development of AUD are still unclear, potentially 
because ethanol consumption alters several neurotransmitter systems and interactions between 
these systems are complex [117]. Identifying ethanol-induced changes to neuronal subtypes may 
uncover which of these subtypes and adaptations are most relevant for ethanol action. As a proof 
of principle, Section 4 studied D1R MSNs in the NAc, which are potentiated by ethanol and 
involved in several ethanol-related behaviors (presented in Section 4); additionally, this study 
used a chronic intermittent vapor ethanol exposure that escalates drinking to identify ethanol-
induced gene regulation in D1R MSNs. While microarray and ChIP results are currently 
pending, optimization studies reveal that the current protocol for studying gene regulation in 
D1R MSNs is technically sound. Taking an unbiased approach by using a whole genome 
expression array may also be a hypothesis-generating experiment, since it could identify as yet 
unknown mechanisms of chronic ethanol important in D1R MSNs. Though this study is new and 
relatively limited in scope, developing tools for epigenetic analysis of neuronal subtypes in vivo 
has potential for improving understanding of ethanol action. 
 In conclusion, these three varied experimental sections revealed new roles of epigenetics 
in ethanol action and ethanol-related behaviors. While the significance of these effects is still not 
fully known, they introduce the idea that ethanol has diverse roles in regulating gene expression 
and these are enacted by several mechanisms at the level of chromatin. More focused studies that 
manipulate chromatin modifying enzymes while studying ethanol-related behaviors are 
necessary to identify which of these are most critical for ethanol action. 
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5.1.2 Future Directions 
This dissertation develops two distinct models. The first is a paternal alcohol model that studies 
heritability of AUD. The second is a cell-type specific model for studying ethanol-induced 
transcriptional regulation. Both of these models have a broad range of potential experiments to 
identify mechanisms of ethanol that are important for the development of AUD. 
 For the paternal alcohol model, questions surround both the molecular mechanisms and 
specific behavioral phenotype that underlies this effect. In particular, decreased ethanol 
consumption was noted at the beginning of a two bottle choice continuous access experiment 
when ethanol concentrations were low. However, there was no effect of paternal ethanol 
exposure on a limited access drinking in the dark experiment using solutions with a high ethanol 
concentration. Considering the complexity of this behavior and variability of individual mice in 
the experiment, it will be challenging to uncover specific mechanisms that regulate this effect. 
Changes to any one of several behavioral pathways could regulate this phenotype in mice – taste 
perception of alcohol, operant learning, stress associated with social isolation, or sensitivity to 
the effects of ethanol. Importantly, earlier studies found an effect of paternal ethanol on learning 
[171] and behaviors that are affected by stress, like grooming [173] and the forced-swim test 
[187]. While we did not see changes in basal behaviors in mice, other measures of stress, like 
measurement of corticosterone levels during a stressful paradigm, or learning may uncover 
effects on these measures in our model. Studying other operant models of ethanol preference or 
drinking, like the conditioned place preference test [287], may disentangle complex effects of 
paternal ethanol on neurodevelopment from a specific effect on ethanol preference. 
  Stress studies in ethanol-sired offspring may be especially important because of the 
previously identified effects of paternal stress on male offspring, which showed blunting of the 
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hypothalamic-pituitary axis and changes in several behavioral measures [77,95]. Additionally, 
considering ethanol exposure potentiates the hypothalamic-pituitary-adrenal axis and is a potent 
stressor [288], sires exposed to vapor ethanol may also experience chronic stress prior to mating. 
Stress experiments in offspring can be tied to ethanol-drinking and ethanol-related behaviors. For 
instance, mice escalate ethanol drinking under certain types of stress [289], so that the two bottle 
choice experiment may have detected an increase in ethanol drinking in the room air group 
following social isolation that was absent in ethanol-sired offspring. Therefore, exposing 
offspring to more potent stressors may reveal a greater difference between ethanol and room air 
sired groups on measures of drinking escalation. There was also a specific effect of paternal 
ethanol on ethanol sensitivity on the EPM; however, even this effect may be explained by 
blunting of a stress response following an ethanol injection rather than a change in sensitivity to 
ethanol-induced anxiolysis. Characterizing the corticosterone response after injection of 1 g/kg 
ethanol may reveal this effect, which could account for increased open arm entries in ethanol-
sired male offspring. Additional effects of pain sensitivity after ethanol injection may also play 
into changes in stress response. Importantly, ethanol stimulates nociceptor receptors in gut 
afferents [290], so that increased ethanol-induced anxiolysis in ethanol-sired male offspring may 
reflect decreased response to the noxious effects of an i.p. injection with ethanol. Using capsaicin 
in the control condition or another mode of ethanol exposure may reduce the potentially 
confounding effects of pain on measures of anxiety. These studies will be important components 
of fully characterizing ethanol drinking and ethanol-related behaviors in offspring of ethanol-
exposed sires. 
 There are several important studies related to other aspects of our paternal ethanol model. 
This study found decreased DNA methylation in sperm at the IG DMR and Bdnf promoter. It 
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will be important to characterize when these changes occur in sperm and how long they last by 
studying sperm at different time points of ethanol exposure. If changes to DNA methylation in 
sperm are found to underlie behavioral effects in offspring, they may be used as a biomarker for 
risk of inheriting ethanol-induced epigenetic modifications. Importantly, this type of biomarker 
can be tested non-invasively through sperm collection, so that our findings in rodent studies can 
also be tested in humans. While dams were only housed with sires for 2 days, it is possible that 
there is an effect of maternal provisioning, a change in maternal care related to exposure to a 
sire’s fitness [91,94]. Cross-fostering experiments will identify the contribution of this 
component to the phenotype. Finally, better characterizing the sperm epigenome following 
ethanol exposure, through studies of sperm RNA populations and histone modifications, may 
identify other epi-alleles contributing to this phenotype. 
 Another important step for uncovering mechanisms of paternal ethanol’s effects on 
offspring is studying changes in gene expression that underlie altered behaviors. Additionally, 
identifying altered genes that drive this phenotype may reveal genes that protect against high 
ethanol consumption. While this study identified increased Bdnf expression in the VTA of male 
offspring, several other changes are likely to exist considering the complexity of the phenotype 
presented. However, it is challenging to separate primary genes altered by a heritable epigenetic 
modification from those that have secondary changes in expression related to altering the 
primary gene. Whole-genome expression studies of offspring are an important future experiment 
that would identify networks of genes altered by paternal ethanol and key-in on affected 
pathways. These studies may also assist in establishing causation, since gene network analysis 
could identify which changes in expression are most robust and drive altered gene networks. 
Coupling these studies to DNA methylation analysis and/or miRNA expression analysis would 
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establish a mechanism by which altered gene expression is encoded in the genome. This type of 
analysis could also provide regions to screen in the F1 generation for potential transfer of 
epialleles to the F2 generation and the study of transgenerational effects. 
 In section 3, significant changes in global levels of histone modifications in CCx and HC 
following acute ethanol suggest broad epigenetic effects of ethanol. Unfortunately, a conserved 
program of histone modifications was not uncovered at the model gene promoters studied. 
Expanding this study to other histone modifications, like histone phosphorylation that was found 
to be altered by memory induction [291], may identify such an effect. Additionally, studying 
smaller brain regions affected by ethanol, like the NAc and VTA, or individual cell types may 
reduce background signal and increase sensitivity to identify histone modifications at gene 
promoters using ChIP. This type of study may also be done using in vitro cell culture 
experiments, where the effects of ethanol can be studied on a homogenous cell type in a very 
controlled environment. In vitro experiments would also separate primary effects of ethanol on 
histone modifications from secondary effects of altered neurotransmitter signaling that may be 
driving some ethanol-induced histone modifications in vivo. However, these in vitro findings will 
likely be challenging to replicate in vivo considering complexity of ethanol action. Therefore, 
while a gene-specific epigenetic program was not identified in CCx, one may be identified in the 
future by expanding histone modifications studied and changing other parameters of the 
experiment. 
 The model in Section 4 of this dissertation presents a more focused, cell-type specific 
method for studying ethanol-induced epigenetic regulation of gene expression. As described, this 
section is currently a proof of principle experiment to show that ethanol alters gene expression 
and histone modifications in D1R MSNs. However, if ethanol-induced effects are established in 
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this model, it can easily be adapted to mechanistic studies of behavior. Notably, variability in 
drinking escalation following chronic vapor ethanol exposure may be explained by epigenetic or 
transcriptional differences in key cell types. It would be especially interesting if mice resistant to 
drinking escalation failed to show expression of a relevant gene or epigenetic priming of a gene 
promoter activated by ethanol. Aside from epigenetic studies, microarray results on their own 
can be used to develop hypotheses about cell-type specific effects of ethanol. These can be 
investigated using cell-type specific knockdown of differentially expressed genes or developing 
integrated ethanol response networks by studying whole genome expression in multiple cell 
types. Finally, FACS and BAC technology allows for comparing multiple cell types within a 
single animal, so that cell types can be compared for their response to ethanol. A D1R vs. D2R 
study will be an important follow-up to this experiment, since these cell types appear to mediate 
different properties of ethanol [292,293]. All of these approaches will likely answer important 
questions regarding which cell types and genes are most critical for ethanol action.  
 In conclusion, this dissertation introduces several important aspects of epigenetic effects 
of ethanol by developing new models of ethanol-induced gene regulation; however, several 
important questions remain and the alcoholism field is only beginning to study specific 
mechanisms by which ethanol regulates gene expression. The future studies presented here will 
expand on the effects of ethanol on heritability of ethanol drinking behaviors and changes in 
histone modifications in the brain, providing more specific mechanisms that underlie the results. 
These will form the foundation to broader experiments on heritability of AUD and targeted 
approaches to modulate chromatin modifying enzymes to reduce the burden of AUD. 
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APPENDIX A 
DISSOCIATION AND FLUORESCENCE ACTIVATED CELL SORTING OF THE 
NUCLEUS ACCUMBENS AND DOWNSTREAM APPLICATIONS: RNA ISOLATION 
AND CHROMATIN IMMUNOPRECIPITATION 
Papain dissociation and cell sorting are adapted from Crook and Housman, 2012, PNAS, 109: 
7487. We are using the Drd1a:tdTomato mouse (Jax #016204) but this protocol can be used for 
any mouse expressing a fluorescent protein. 
 
Reagents and materials: 
• HABG (prepare fresh day of experiment):  
o 9.8 ml Hibernate A (Gibco # A12475-01) 
o 200 ul B27 (Gibco # 17504-044) 
o 25 ul Glutamax (Gibco #35050-061) 
• Papain dissociation buffer (prepare fresh day of experiment):  
o 5.5 mL Hibernate E (Brain Bits) 
o 14 ul Glutamax (Gibco #35050-061) 
• Papain (Worthington Biochemical #LK003176) 
• Trizol LS (Ambion #10296-028) 
• DNase (Worthington Biochem #LK003170) 
• Ribolock RNase Inhibitor (Fermentas #EO0381) 
• Sodium butyrate (Sigma, #B5887) 
• Protease Inhibitor Cocktail (Roche cOmplete, # 04693116001) 
• Magna ChIP protein A/G beads (Millipore, #16-663) 
• Micrococcal nuclease (New England Biolabs, #M0247S) 
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• Antibodies: anti-H3K18ac (#9675, Cell Signaling Technology), anti-H3K27me3 (#17-
622, Millipore), nonspecific IgG as a negative control (#PP64B, Millipore) 
• Aluminum foil 
• Rodent stainless steel brain matrix for 1 mm coronal slices (Zivic Instruments) 
• Pasteur pipets fire polished to a 0.5 mm opening 
• Surgical equipment: PBS, razors, scalpels, forceps, etc. 
• 15 ml and 50 ml RNase-free tubes 
• 70 ul cell strainer 
• Nuclease free 15 ml (Invitrogen, # AM12500) and 50 ml (#AM12501) conical tubes 
• Petri dishes 
• Small Tissue Culture Dish (Falcon #353001) 
• Dissecting microscope  
• Pipets and cut pipet tips 
• Nuclease free water, not DEPC-treated (Ambion, #AM9937) 
• RNeasy mini kit 
• RNase Zap (Ambion, # AM9780) 
• Qiagen MinElute Reaction Cleanup Kit 
• Magnetic tube rack (Millipore) 
Prepare ChIP reagents (These can be stored at room temperature for weeks): 
• 2x MNase buffer: 100 mM Tris, pH 8.0, 2 mM CaCl2, 0.4% Triton X-100 
• 1x MNase buffer: 50 mM Tris, pH 8.0, 1 mM CaCl2, 0.2% Triton X-100 
• 10x  MNase stop buffer: 110 mM Tris, pH 8.0, 55mM EDTA 
• 2x RIPA lysis buffer: 280 mM NaCl, 1.8% Triton X-100, 0.2% SDS, 0.2% Na 
Deoxycholate, and 5 mM EGTA 
• 1x RIPA wash buffer: 10 mM Tris, pH 8.0, 1 mM EDTA, 140 mM NaCl, 1% Triton X-
100, 0.1% SDS, 0.1% Na Deoxycholate 
• TE buffer: 10 mM Tris, pH 8.0, 1 mM EDTA 
• Elution buffer: 50 mM NaCl, 20 mM Tris, pH 8.0, 5 mM EDTA, 1% SDS, 50 μg/ml 
proteinase K 
• 3 M Na Acetate 
Prepare DNase, Papain, and HABG fresh on the day of the experiment: 
• DNase: add 500 ul Papain dissocation buffer to vial of DNase and invert to mix; store on 
ice 
• Papain: add 5 ml Papain dissociation buffer to vial of Papain and invert to mix; pipet 2 ml 
into 15 ml nuclease-free tube 
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o Incubate papain in 15 ml tube at 37 degrees C for ~20 minutes prior to 
dissociation 
• HABG: Pipet 1 ml HABG into Small Tissue Culture Dish and add 2.5 ul Ribolock (~100 
U/ml) 
Prepare surgical equipment: 
• Clean all equipment thoroughly with 70% EtOH 
• Incubate brain matrix on ice for at least 15 minutes 
• Place 4 razors in ice cold PBS for brain matrix 
• Cut ~1 cm off the tip of four 1 ml pipet tips using a clean razor blade 
Dissociation Protocol: 
1. Sacrifice mouse by cervical dislocation and decapitate using razor blade 
2. Extract whole brain from skull and place into chilled brain matrix 
3. Insert razor blades into matrix to generate 1 mm thick coronal slices (about 5 razor blades 
starting at the rostral end of the brain are sufficient to cover the full length of the NAc) 
4. Dissect NAc core from slices carefully; do not collect overlying caudate (caudate tissue 
appears striated under the microscope while NAc tissue is solid and greyish surrounding 
the anterior commissure) 
5. Place NAc pieces into 1 mL HABG supplemented with Ribolock (100 U/ml) and cut into 
~1 mm pieces 
6. Remove Papain from incubator and add 110 ul DNase to tube 
7. Use cut pipet tip to collect NAc pieces and place tip into incubated Papain – allow the 
tissue pieces to slowly fall into Papain and gently agitate the pipet tip to encourage them 
to leave the pipet; DO NOT pipet HABG directly into Papain, as the ions will inhibit 
dissociation 
8. Cover with aluminum foil and incubate in papain at 32 degrees C for 15 minutes with 
gentle rotation 
9. While dissociating, pipet 2 ml HABG into a 15 ml RNase-free tube; add 5 ul Ribolock 
(~100 U/ml), sodium butyrate to 5 mM (10 ul of 1 M stock), 200 ul of 10x protease 
inhibitor in PBS 
10. For ChIP only, prepare 250 ul MNase buffer supplemented with sodium butyrate to 5 
mM and protease inhibitor in a 15 ml RNase-free tube 
11. For RNA only, prepare 750 ul Trizol LS in a 15 ml RNase-free tube 
12. After 20 minutes, pipet tissue pieces from papain using a cut pipet tip and place tip into 
HABG supplemented with Ribolock; allow tissue pieces to slowly fall into HABG and 
agitate tip as necessary (you may have to repeat this a couple of times as tissue pieces are 
stickier in Papain) 
13. Cover tube with aluminum foil and incubate at room temperature for 5 minutes 
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14. While incubating, fit a 70 um cell strainer over the top of a 50 ml RNase-free conical tube 
15. Triturate the tissue pieces using a fire polished Pasteur pipet with a small opening (~0.5 
mm) – pipet pieces up and down over 4 seconds about 10-20 times until there are no 
longer large visible pieces; the HABG should now appear cloudy 
16. Use a cut pipet tip to pipet the dissociated cell suspension in HABG (800 ul at a time) 
through the 70 um cell strainer and let solution filter 
17. Add ~5ml HABG supplemented with 10 ul Ribolock (~100 U/ml), sodium butyrate to 5 
mM (25 ul of 1 M stock), 500 ul of 10x protease inhibitor in PBS directly through the cell 
strainer so that the total volume is ~7 ml 
18. Cover tube with aluminum foil to prevent quenching of fluorescence and proceed directly 
to sorting; keep tube at room temperature 
Cell sorting: 
These parameters will change depending on the machine and type of fluorescent protein. Work 
with the flow cytometry core to get the best separation of fluorescent cells with highest yield. 
Using the FACS Aria II (Becton Dickinson) with an 85 μm nozzle and a pressure of 45 p.s.i, we 
have had success isolating neurons by setting the gates to side scatter (SSC) less than 150,000 
and forward scatter (FSC) greater than 50,000. Set gates for fluorescence by comparing wild type 
strain to fluorescent strain. Sort cells directly into Trizol LS (for RNA) or 2x MNase (for ChIP) 
to prevent degradation of RNA and chromatin, respectively. 
 
RNA isolation: 
1. Prepare an RNase free surface and clean pipets using an RNase inhibitor (we use RNase 
Zap) 
2. Centrifuge Trizol LS with cells at 200 g for a few seconds to bring down cells into Trizol 
3. Transfer Trizol LS with sorted cells to RNase free 1.5 mL eppendorf tube and check 
volume; add RNase free water to bring volume up to 1 ml 
4. Add 200 ul chloroform and shake vigorously for 15 seconds 
5. Allow tube to sit at room temperature for 2 minutes 
6. Centrifuge at 10,000 g for  8 minutes at 4 degrees C 
7. Transfer aqueous layer to a new tube (~550 ul) 
8. Add 1 volume of 70% EtOH to aqueous layer and mix by pipetting mixture 
9. Add 700 ul of solution to RNeasy mini column and centrifuge at 10,000 g for 1 minute at 
room temperature with slow acceleration 
10. Repeat this step with remaining solution 
11. Add 700 ul buffer RW1 and centrifuge at 10,000 g for 30s at room temperature 
12. Add 500 ul buffer RPE and centrifuge at 10,000 g for 30s at room temperature 
13. Repeat step 10 
14. Transfer to a new collection tube and centrifuge at 10,000 g for 1 minute at room 
temperature to remove residual ethanol 
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15. Transfer to an RNase free 1.5 mL eppendorf tube, add 30 ul RNase free water directly to 
the membrane, and incubate at room temperature for 2 minutes 
16. Centrifuge at 10,000 g for 1 minute at room temperature 
17. Store RNA at -80 degrees C until ready to use 
18. For RT-qPCR, this protocol used a 30 ul Bio-Rad RT reaction (23 ul RNA in water, 6 ul 
5x RT reaction buffer, 1 ul RT); 5 ul of this this reaction per well. This can be done for 
assessing expression of 3 genes in duplicate; diluting the final RT reaction can increase 
the number of detected genes, but will reduce signal. 
ChIP procedure: 
1. Sort cells directly into 250 μl of 2x MNase buffer supplemented with sodium butyrate to 
5 mM and protease inhibitor cocktail 
2. Centrifuge briefly at 100 g to bring any residual buffer to the bottom of the tube 
3. Collect 2x MNase buffer with sorted cells into a 1.5 ml nuclease free Eppendorf tube 
4. Bring volume up to 500 μl by adding nuclease free water (all steps are at room 
temperature at this point) 
5. Dilute MNase by adding 1 μl of MNase (2,000 gel units) to 500 μl 1x MNase buffer 
6. For MNase digestion of chromatin, add 15 μl of diluted MNase to sorted cells and cells 
and incubate in a 37˚ C heat block for 5 minutes 
7. To stop the MNase digestion, add 50 μl of 10x MNase stop buffer to the solution.  
8. From this point, chromatin is kept on ice or in a 4˚ C room 
9. To lyse cells, add 550 μl of ice cold 2x RIPA cell lysis buffer supplemented with sodium 
butyrate up to 5 mM and protease inhibitor cocktail  
10. Mixed by inverting the tube and leave on ice for 15 minutes  
11. To remove cell debris, centrifuge chromatin at 4˚ C at 13,000 rpm for 10 minutes 
12. Decant the supernatant into a new 1.5 ml Eppendorf tube and place on ice 
13. Chromatin volume should be ~1 mL at this point. Divide this volume into two 400 μl 
aliquots for immunoprecipitation (IP) and one 200 μl aliquot to be used as input  
14. For IP reactions add 22 μl of MagnaChIP Protein A/G magnetic beads to each tube 
15. Add antibodies to each IP tube (this will vary for each antibody and needs to be 
optimized). It may be challenging to quantify chromatin if it is divided into more than 2 
IP reactions; though this could be possible with a larger number of cells collected. For 
this experiment, 5 μl of an anti-H3K27me3 antibody was added to one tube and 9 μl of an 
anti-H3K18ac antibody was added to the other tube. It is also important to perform a 
negative control initially to ensure the ChIP reaction is specific, which can be done by 
adding 5 μl of nonspecific IgG antibody in place of one of the antibodies. 
16. Incubate the immunoprecipitation tubes at 4˚ C with gentle end-over-end rotation for 3.5 
hours; keep the input tube at 4˚ C with no rotation during this time 
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17. After incubation, place IP tubes onto a magnetic rack and remove the supernatant using a 
pipet (be careful not to agitate the magnetic beads; no magnetic beads should be removed 
by the pipet tip with the supernatant at any point). 
18. Elute magnetic beads in 500 μl RIPA wash buffer and incubate at 4˚ C with gentle end-
over-end rotation for 5 minutes; after incubation, place tubes on the magnetic rack and 
remove supernatant as before 
19. Repeat the RIPA wash buffer step two more times (3 total washes in RIPA wash buffer), 
then wash the magnetic beads 1 time with 500 μl TE buffer (these may need to be 
optimized as well depending on the antibody, though these washes are sufficient to 
remove background using the antibodies in this study) 
20. Following the TE wash step, elute magnetic beads in 200 μl elution buffer 
21. For the input, add proteinase K to a concentration of 50 μg/ml  
22. Incubate the magnetic beads in elution buffer and input at 65˚ C with gentle rotation for 
45 minutes 
23. Following proteinase K digestion, briefly spin tubes on a tabletop centrifuge and place 
them into a magnetic rack 
24. Transfer the supernatant (200 μl) to a tube containing 10 μl 3 M Na Acetate and 1 ml 
buffer PB 
25. Purify DNA using the Qiagen MinElute Reaction Cleanup Kit according to the 
manufacturer’s protocol and elute in 14 μl nuclease free water 
26. For this study, DNA from IP reactions was quantified by the Pitt Genetics and 
Proteomics Core Lab using a Qubit Fluorometer; the amount of DNA recovered will 
depend on the number of cells collected but should be ~1 ng/ul for the input and 
H3K27me3 reactions and ~0.7 ng/ul for the H3K18ac reaction from ~20,000 cells; there 
should be no DNA detected using the nonspecific IgG antibody. 
27. Following IP reactions, levels of enrichment for a particular locus can be quantified using 
qPCR or other downstream quantitative application 
28. For this study, 16 ul of nuclease-free water were added to eluted DNA (14 ul) for a total 
of 30 ul. 5 ul of diluted DNA were used in each well as a template for a qPCR reaction. 
Therefore, 3 primer pairs were tested in duplicate, though this can be optimized 
depending on number of cells collected and antibody enrichment. 
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APPENDIX B 
EXPRESSION OF CHROMATIN MODIFYING ENZYMES IN THE CEREBRAL 
CORTEX FOLLOWING ACUTE ETHANOL 
Gene Fold Regulation p-value Gene Function 
Kdm1a -0.27 0.27 Lysine (K)-specific demethylase 1A 
Ash1l -0.30 0.33 Ash1 (absent, small, or homeotic)-like 
Atf2 0.17 0.80 Activating transcription factor 2 
Aurka 0.37 0.42 Aurora kinase A 
Aurkb 0.20 0.48 Aurora kinase B 
Aurkc -0.10 0.64 Aurora kinase C 
Carm1 -0.13 0.58 Coactivator-associated arginine methyltransferase 1 
Cdyl -0.30 0.35 Chromodomain protein, Y chromosome-like 
Ciita 0.03 0.93 Class II transactivator 
Csrp2bp -0.77 0.08 Cysteine and glycine-rich protein 2 binding protein 
Dnmt1 0.23 0.74 DNA methyltransferase 1 
Dnmt3a 0.20 0.36 DNA methyltransferase 3A 
Dnmt3b 0.20 0.77 DNA methyltransferase 3B 
Dot1l -0.20 0.26 DOT1-like, histone H3 methyltransferase 
Dzip3 0.00 0.96 DAZ interacting protein 3, zinc finger 
Ehmt1 0.10 0.94 Euchromatic histone methyltransferase 1 
Ehmt2 -0.30 0.33 Euchromatic histone lysine N-methyltransferase 2 
Esco1 -0.30 0.50 Establishment of cohesion 1 homolog 1 
Esco2 -0.43 0.21 Establishment of cohesion 1 homolog 2 
Hat1 -0.10 0.49 Histone aminotransferase 1 
Hdac1 0.27 0.52 Histone deacetylase 1 
Hdac10 0.13 0.40 Histone deacetylase 10 
Hdac11 -0.40 0.00 Histone deacetylase 11 
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Gene Fold Regulation p-value Gene Function 
Hdac2 -2.03 0.20 Histone deacetylase 2 
Hdac3 0.33 0.21 Histone deacetylase 3 
Hdac4 -0.10 0.51 Histone deacetylase 4 
Hdac5 -0.13 0.53 Histone deacetylase 5 
Hdac6 -0.30 0.16 Histone deacetylase 6 
Hdac7 -0.17 0.33 Histone deacetylase 7 
Hdac8 -0.80 0.22 Histone deacetylase 8 
Hdac9 -0.33 0.27 Histone deacetylase 9 
Kdm5b -0.23 0.33 Lysine (K)-specific demethylase 5B 
Kdm5c -0.10 0.61 Lysine (K)-specific demethylase 5C 
Kdm4a -0.10 0.50 Lysine (K)-specific demethylase 4A 
Kdm4c -0.03 0.92 Lysine (K)-specific demethylase 4C 
Kdm6b -0.37 0.27 KDM1 lysine (K)-specific demethylase 6B 
Kat2a -0.17 0.64 K(lysine) acetyltransferase 2A 
Kat2b 0.93 0.05 K(lysine) acetyltransferase 2B 
Kat5 0.83 0.17 K(lysine) acetyltransferase 5 
Mll3 -0.03 0.76 Myeloid/lymphoid or mixed-lineage leukemia 3 
Mll5 0.73 0.19 Myeloid/lymphoid or mixed-lineage leukemia 5 
Mysm1 -0.33 0.27 Myb-like, SWIRM and MPN domains 1 
Myst1 0.23 0.16 MYST histone acetyltransferase 1 
Myst2 0.03 0.91 MYST histone acetyltransferase 2 
Myst3 0.13 0.56 MYST histone acetyltransferase (monocytic leukemia) 3 
Myst4 -0.40 0.27 MYST histone acetyltransferase monocytic leukemia 4 
Ncoa1 -0.20 0.23 Nuclear receptor coactivator 1 
Ncoa3 0.10 0.95 Nuclear receptor coactivator 3 
Ncoa6 0.27 0.36 Nuclear receptor coactivator 6 
Nek6 -0.13 0.49 NIMA (never in mitosis gene a)-related expressed kinase 6 
Nsd1 0.10 0.36 Nuclear receptor-binding SET-domain protein 1 
Pak1 -0.10 0.60 P21 protein (Cdc42/Rac)-activated kinase 1 
Prmt1 -0.17 0.26 Protein arginine N-methyltransferase 1 
Prmt2 -0.23 0.46 Protein arginine N-methyltransferase 2 
Prmt3 -0.03 0.81 Protein arginine N-methyltransferase 3 
Prmt5 0.07 0.80 Protein arginine N-methyltransferase 5 
Prmt6 0.30 0.29 Protein arginine N-methyltransferase 6 
Prmt7 -0.10 0.65 Protein arginine N-methyltransferase 7 
Prmt8 0.13 0.72 Protein arginine N-methyltransferase 8 
Rnf2 -0.13 0.55 Ring finger protein 2 
Rnf20 -0.20 0.53 Ring finger protein 20 
Rps6ka3 -0.33 0.23 Ribosomal protein S6 kinase polypeptide 3 
Rps6ka5 0.17 0.43 Ribosomal protein S6 kinase, polypeptide 5 
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Gene Fold Regulation p-value Gene Function 
Setd1a 0.00 0.94 SET domain containing 1A 
Setd1b -0.03 0.85 SET domain containing 1B 
Setd2 -0.07 0.73 SET domain containing 2 
Setd3 0.10 0.82 SET domain containing 3 
Setd4 0.30 0.33 SET domain containing 4 
Setd5 0.20 0.61 SET domain containing 5 
Setd6 -0.13 0.65 SET domain containing 6 
Setd7 -0.07 0.70 SET domain containing (lysine methyltransferase) 7 
Setd8 0.20 0.77 SET domain containing (lysine methyltransferase) 8 
Setdb1 -0.03 0.88 SET domain, bifurcated 1 
Setdb2 0.27 0.27 SET domain, bifurcated 2 
Smyd1 0.20 0.15 SET and MYND domain containing 1 
Smyd3 0.00 0.99 SET and MYND domain containing 3 
Suv39h1 0.07 0.23 Suppressor of variegation 3-9 homolog 1 
Suv420h1 -0.23 0.31 Suppressor of variegation 4-20 homolog 1 
Ube2a 0.89 0.51 Ubiquitin-conjugating enzyme E2A, RAD6 homolog 
Ube2b 0.91 0.44 Ubiquitin-conjugating enzyme E2B, RAD6 homology 
Usp16 1.04 0.92 Ubiquitin specific peptidase 16 
Usp21 0.89 0.61 Ubiquitin specific peptidase 21 
Usp22 1.20 0.45 Ubiquitin specific peptidase 22 
Whsc1 1.14 0.40 Wolf-Hirschhorn syndrome candidate 1 
*Bold genes were validated using additional samples (Fig. 19) 
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